source	target	number_of_paths	node_type	node_value	node_count
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	NGLY1::NCBIGene:55768_in 1 to 1 orthology relationship with_Pngl::FlyBase:FBgn0033050	688
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Pngl::FlyBase:FBgn0033050_has phenotype_short lived::FBcv:0000385	48
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	short lived::FBcv:0000385_has phenotype_Egfr::FlyBase:FBgn0003731	40
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Egfr::FlyBase:FBgn0003731_in 1 to 1 orthology relationship with_Egfr::MGI:95294	144
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Egfr::MGI:95294_involved in_wound healing::GO:0042060	36
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	wound healing::GO:0042060_involved in_AQP1::NCBIGene:358	72
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Pngl::FlyBase:FBgn0033050_has phenotype_Drosophila embryo phenotype::FBbt:00000052PHENOTYPE	116
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Drosophila embryo phenotype::FBbt:00000052PHENOTYPE_has phenotype_Jra::FlyBase:FBgn0001291	48
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Jra::FlyBase:FBgn0001291_in 1 to 1 orthology relationship with_Jun::MGI:96646	48
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Jun::MGI:96646_involved in_positive regulation of epithelial cell migration::GO:0010634	8
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	positive regulation of epithelial cell migration::GO:0010634_involved in_AQP1::NCBIGene:358	32
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Pngl::FlyBase:FBgn0033050_has phenotype_partially lethal - majority die::FBcv:0000352	104
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	partially lethal - majority die::FBcv:0000352_has phenotype_Jra::FlyBase:FBgn0001291	48
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Jra::FlyBase:FBgn0001291_in 1 to 1 orthology relationship with_JUN::NCBIGene:3725	24
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	JUN::NCBIGene:3725_involved in_positive regulation of fibroblast proliferation::GO:0048146	8
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	positive regulation of fibroblast proliferation::GO:0048146_involved in_AQP1::NCBIGene:358	140
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Jra::FlyBase:FBgn0001291_in 1 to 1 orthology relationship with_Jun::RGD:2943	16
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Jun::RGD:2943_None_positive regulation of fibroblast proliferation::GO:0048146	8
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Pngl::FlyBase:FBgn0033050_has phenotype_Drosophila tarsal segment 4 phenotype::FBbt:00004651PHENOTYPE	40
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Drosophila tarsal segment 4 phenotype::FBbt:00004651PHENOTYPE_has phenotype_Egfr::FlyBase:FBgn0003731	40
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Egfr::MGI:95294_involved in_positive regulation of fibroblast proliferation::GO:0048146	36
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Pngl::FlyBase:FBgn0033050_has phenotype_female sterile::FBcv:0000366	60
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	female sterile::FBcv:0000366_has phenotype_Hcf::FlyBase:FBgn0039904	8
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Hcf::FlyBase:FBgn0039904_in 1 to 1 orthology relationship with_Hcfc1::MGI:105942	12
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Hcfc1::MGI:105942_is part of_axon::GO:0030424	12
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	axon::GO:0030424_is part of_AQP1::NCBIGene:358	48
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Egfr::FlyBase:FBgn0003731_in 1 to 1 orthology relationship with_EGFR::NCBIGene:1956	108
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	EGFR::NCBIGene:1956_is part of_nuclear membrane::GO:0031965	36
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	nuclear membrane::GO:0031965_is part of_AQP1::NCBIGene:358	44
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	partially lethal - majority die::FBcv:0000352_has phenotype_Egfr::FlyBase:FBgn0003731	40
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Egfr::FlyBase:FBgn0003731_in 1 to 1 orthology relationship with_Egfr::RGD:2543	108
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Egfr::RGD:2543_None_cellular response to mechanical stimulus::GO:0071260	36
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	cellular response to mechanical stimulus::GO:0071260_involved in_AQP1::NCBIGene:358	108
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Egfr::RGD:2543_None_cellular response to dexamethasone stimulus::GO:0071549	36
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	cellular response to dexamethasone stimulus::GO:0071549_involved in_AQP1::NCBIGene:358	72
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Drosophila embryo phenotype::FBbt:00000052PHENOTYPE_has phenotype_Egfr::FlyBase:FBgn0003731	40
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	EGFR::NCBIGene:1956_involved in_wound healing::GO:0042060	36
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Jun::RGD:2943_None_positive regulation of epithelial cell migration::GO:0010634	8
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	JUN::NCBIGene:3725_involved in_positive regulation of epithelial cell migration::GO:0010634	8
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Pngl::FlyBase:FBgn0033050_has phenotype_developmental rate defective::FBcv:0000450	68
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	developmental rate defective::FBcv:0000450_has phenotype_sgg::FlyBase:FBgn0003371	28
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	sgg::FlyBase:FBgn0003371_in 1 to 1 orthology relationship with_Gsk3b::MGI:1861437	96
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Gsk3b::MGI:1861437_involved in_cellular response to mechanical stimulus::GO:0071260	24
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	developmental rate defective::FBcv:0000450_has phenotype_Egfr::FlyBase:FBgn0003731	40
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Pngl::FlyBase:FBgn0033050_has phenotype_lethal - all die before end of P-stage::FBcv:0002000	28
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	lethal - all die before end of P-stage::FBcv:0002000_has phenotype_sgg::FlyBase:FBgn0003371	28
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Pngl::FlyBase:FBgn0033050_has phenotype_some die during pharate adult stage::FBcv:0002038	28
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	some die during pharate adult stage::FBcv:0002038_has phenotype_sgg::FlyBase:FBgn0003371	28
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	sgg::FlyBase:FBgn0003371_in 1 to 1 orthology relationship with_Gsk3b::RGD:70982	48
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Gsk3b::RGD:70982_None_cellular response to hydrogen peroxide::GO:0070301	24
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	cellular response to hydrogen peroxide::GO:0070301_involved in_AQP1::NCBIGene:358	24
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Egfr::MGI:95294_None_positive regulation of fibroblast proliferation::GO:0048146	36
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Pngl::FlyBase:FBgn0033050_has phenotype_wing margin phenotype::FBbt:00005378PHENOTYPE	40
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	wing margin phenotype::FBbt:00005378PHENOTYPE_has phenotype_Egfr::FlyBase:FBgn0003731	40
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Gsk3b::MGI:1861437_involved in_negative regulation of apoptotic process::GO:0043066	24
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	negative regulation of apoptotic process::GO:0043066_involved in_AQP1::NCBIGene:358	112
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Hcf::FlyBase:FBgn0039904_in 1 to 1 orthology relationship with_HCFC1::NCBIGene:3054	12
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	HCFC1::NCBIGene:3054_is part of_axon::GO:0030424	12
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Pngl::FlyBase:FBgn0033050_has phenotype_Drosophila pretarsus phenotype::FBbt:00004653PHENOTYPE	40
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Drosophila pretarsus phenotype::FBbt:00004653PHENOTYPE_has phenotype_Egfr::FlyBase:FBgn0003731	40
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Egfr::RGD:2543_None_positive regulation of fibroblast proliferation::GO:0048146	36
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	short lived::FBcv:0000385_has phenotype_bchs::FlyBase:FBgn0043362	4
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	bchs::FlyBase:FBgn0043362_in 1 to 1 orthology relationship with_WDFY3::NCBIGene:23001	8
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	WDFY3::NCBIGene:23001_is part of_nuclear membrane::GO:0031965	8
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Jun::MGI:96646_involved in_negative regulation of apoptotic process::GO:0043066	8
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Pngl::FlyBase:FBgn0033050_has phenotype_wing vein phenotype::FBbt:00004751PHENOTYPE	76
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	wing vein phenotype::FBbt:00004751PHENOTYPE_has phenotype_sgg::FlyBase:FBgn0003371	28
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	NGLY1::NCBIGene:55768_in 1 to 1 orthology relationship with_Ngly1::MGI:1913276	12
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Ngly1::MGI:1913276_has phenotype_Abnormality of cell physiology::HP:0011017	12
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Abnormality of cell physiology::HP:0011017_has phenotype_Traf2::MGI:101835	8
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Traf2::MGI:101835_in 1 to 1 orthology relationship with_TRAF2::NCBIGene:7186	4
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	TRAF2::NCBIGene:7186_involved in_cellular response to nitric oxide::GO:0071732	4
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	cellular response to nitric oxide::GO:0071732_involved in_AQP1::NCBIGene:358	8
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Pngl::FlyBase:FBgn0033050_has phenotype_Drosophila wing blade phenotype::FBbt:00006015PHENOTYPE	28
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Drosophila wing blade phenotype::FBbt:00006015PHENOTYPE_has phenotype_sgg::FlyBase:FBgn0003371	28
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Gsk3b::MGI:1861437_None_cellular response to mechanical stimulus::GO:0071260	24
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	female sterile::FBcv:0000366_has phenotype_Egfr::FlyBase:FBgn0003731	40
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Egfr::MGI:95294_involved in_negative regulation of apoptotic process::GO:0043066	36
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	EGFR::NCBIGene:1956_involved in_cellular response to dexamethasone stimulus::GO:0071549	36
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	female sterile::FBcv:0000366_has phenotype_RpS27A::FlyBase:FBgn0003942	4
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	RpS27A::FlyBase:FBgn0003942_in 1 to 1 orthology relationship with_RPS27A::NCBIGene:6233	16
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	RPS27A::NCBIGene:6233_involved in_negative regulation of apoptotic process::GO:0043066	16
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	partially lethal - majority die::FBcv:0000352_has phenotype_RpS27A::FlyBase:FBgn0003942	4
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	wing vein phenotype::FBbt:00004751PHENOTYPE_has phenotype_Egfr::FlyBase:FBgn0003731	40
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Drosophila embryo phenotype::FBbt:00000052PHENOTYPE_has phenotype_sgg::FlyBase:FBgn0003371	28
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Gsk3b::MGI:1861437_is part of_axon::GO:0030424	24
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	female sterile::FBcv:0000366_has phenotype_beta4GalNAcTA::FlyBase:FBgn0027538	4
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	beta4GalNAcTA::FlyBase:FBgn0027538_in 1 to 1 orthology relationship with_B4GALT1::NCBIGene:2683	12
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	B4GALT1::NCBIGene:2683_is part of_brush border membrane::GO:0031526	12
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	brush border membrane::GO:0031526_is part of_AQP1::NCBIGene:358	12
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Gsk3b::RGD:70982_None_cellular response to mechanical stimulus::GO:0071260	24
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	wing vein phenotype::FBbt:00004751PHENOTYPE_has phenotype_Hcf::FlyBase:FBgn0039904	8
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Pngl::FlyBase:FBgn0033050_has phenotype_male sterile::FBcv:0000370	8
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	male sterile::FBcv:0000370_has phenotype_beta4GalNAcTA::FlyBase:FBgn0027538	4
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Jun::MGI:96646_involved in_response to drug::GO:0042493	8
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	response to drug::GO:0042493_involved in_AQP1::NCBIGene:358	24
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Jun::MGI:96646_None_positive regulation of fibroblast proliferation::GO:0048146	8
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	sgg::FlyBase:FBgn0003371_in 1 to 1 orthology relationship with_GSK3B::NCBIGene:2932	24
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	GSK3B::NCBIGene:2932_involved in_negative regulation of apoptotic process::GO:0043066	24
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	JUN::NCBIGene:3725_involved in_response to drug::GO:0042493	8
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	male sterile::FBcv:0000370_has phenotype_RpS27A::FlyBase:FBgn0003942	4
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	female sterile::FBcv:0000366_has phenotype_bchs::FlyBase:FBgn0043362	4
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Traf2::MGI:101835_in 1 to 1 orthology relationship with_Traf2::RGD:1310457	4
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Traf2::RGD:1310457_None_cellular response to nitric oxide::GO:0071732	4
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Jun::MGI:96646_involved in_positive regulation of fibroblast proliferation::GO:0048146	8
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Jra::FlyBase:FBgn0001291_in 1 to 1 orthology relationship with_jun::ZFIN:ZDB-GENE-030131-7859	8
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	jun::ZFIN:ZDB-GENE-030131-7859_involved in_response to drug::GO:0042493	8
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	partially lethal - majority die::FBcv:0000352_has phenotype_Hcf::FlyBase:FBgn0039904	8
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Jun::MGI:96646_None_positive regulation of epithelial cell migration::GO:0010634	8
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Abnormality of cell physiology::HP:0011017_has phenotype_App::MGI:88059	4
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	App::MGI:88059_in 1 to 1 orthology relationship with_App::RGD:2139	4
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	App::RGD:2139_None_cellular response to cAMP::GO:0071320	4
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	cellular response to cAMP::GO:0071320_involved in_AQP1::NCBIGene:358	4
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	short lived::FBcv:0000385_has phenotype_RpS27A::FlyBase:FBgn0003942	4
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	Pngl::FlyBase:FBgn0033050_has phenotype_partially lethal - majority live::FBcv:0000350	4
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	partially lethal - majority live::FBcv:0000350_has phenotype_beta4GalNAcTA::FlyBase:FBgn0027538	4
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	partially lethal - majority die::FBcv:0000352_has phenotype_RpL40::FlyBase:FBgn0003941	4
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	RpL40::FlyBase:FBgn0003941_in 1 to 1 orthology relationship with_UBA52::NCBIGene:7311	4
NGLY1::NCBIGene:55768	AQP1::NCBIGene:358	700	UBA52::NCBIGene:7311_involved in_negative regulation of apoptotic process::GO:0043066	4
NGLY1::NCBIGene:55768	Aqp1::NCBIGene:11826	0	NA	0
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	NGLY1::NCBIGene:55768_in 1 to 1 orthology relationship with_Pngl::FlyBase:FBgn0033050	320
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Pngl::FlyBase:FBgn0033050_has phenotype_short lived::FBcv:0000385	32
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	short lived::FBcv:0000385_has phenotype_inc::FlyBase:FBgn0025394	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	inc::FlyBase:FBgn0025394_in 1 to 1 orthology relationship with_kctd5a::ZFIN:ZDB-GENE-030131-727	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	kctd5a::ZFIN:ZDB-GENE-030131-727_enables_protein complex binding::GO:0032403	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	protein complex binding::GO:0032403_enables_NFE2L1::NCBIGene:4779	28
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Pngl::FlyBase:FBgn0033050_has phenotype_Drosophila embryo phenotype::FBbt:00000052PHENOTYPE	48
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Drosophila embryo phenotype::FBbt:00000052PHENOTYPE_has phenotype_TER94::FlyBase:FBgn0261014	20
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	TER94::FlyBase:FBgn0261014_in 1 to 1 orthology relationship with_VCP::NCBIGene:7415	32
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	VCP::NCBIGene:7415_is part of_endoplasmic reticulum membrane::GO:0005789	16
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	endoplasmic reticulum membrane::GO:0005789_is part of_NFE2L1::NCBIGene:4779	92
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Pngl::FlyBase:FBgn0033050_has phenotype_partially lethal - majority die::FBcv:0000352	60
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	partially lethal - majority die::FBcv:0000352_has phenotype_cnc::FlyBase:FBgn0262975	16
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	cnc::FlyBase:FBgn0262975_in 1 to 1 orthology relationship with_nfe2::ZFIN:ZDB-GENE-030124-1	32
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	nfe2::ZFIN:ZDB-GENE-030124-1_enables_transcription regulatory region sequence-specific DNA binding::GO:0000976	16
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	transcription regulatory region sequence-specific DNA binding::GO:0000976_enables_NFE2L1::NCBIGene:4779	48
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	partially lethal - majority die::FBcv:0000352_has phenotype_Stat92E::FlyBase:FBgn0016917	8
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Stat92E::FlyBase:FBgn0016917_in 1 to 1 orthology relationship with_stat5a::ZFIN:ZDB-GENE-030820-2	32
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	stat5a::ZFIN:ZDB-GENE-030820-2_involved in_erythrocyte differentiation::GO:0030218	16
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	erythrocyte differentiation::GO:0030218_involved in_NFE2L1::NCBIGene:4779	32
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Pngl::FlyBase:FBgn0033050_has phenotype_male sterile::FBcv:0000370	52
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	male sterile::FBcv:0000370_has phenotype_cnc::FlyBase:FBgn0262975	16
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	cnc::FlyBase:FBgn0262975_in 1 to 1 orthology relationship with_NFE2::NCBIGene:4778	16
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	NFE2::NCBIGene:4778_enables_transcription regulatory region sequence-specific DNA binding::GO:0000976	16
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	partially lethal - majority die::FBcv:0000352_has phenotype_Jra::FlyBase:FBgn0001291	24
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Jra::FlyBase:FBgn0001291_in 1 to 1 orthology relationship with_JUN::NCBIGene:3725	16
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	JUN::NCBIGene:3725_enables_RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980	8
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980_enables_NFE2L1::NCBIGene:4779	32
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	JUN::NCBIGene:3725_involved in_transcription from RNA polymerase II promoter::GO:0006366	8
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	transcription from RNA polymerase II promoter::GO:0006366_involved in_NFE2L1::NCBIGene:4779	32
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Jra::FlyBase:FBgn0001291_in 1 to 1 orthology relationship with_Jun::MGI:96646	24
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Jun::MGI:96646_enables_RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980	8
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Pngl::FlyBase:FBgn0033050_has phenotype_wing vein phenotype::FBbt:00004751PHENOTYPE	24
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	wing vein phenotype::FBbt:00004751PHENOTYPE_has phenotype_CG3815::FlyBase:FBgn0029861	8
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	CG3815::FlyBase:FBgn0029861_in 1 to 1 orthology relationship with_Phf12::MGI:1924057	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Phf12::MGI:1924057_enables_transcription cofactor activity::GO:0003712	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	transcription cofactor activity::GO:0003712_enables_NFE2L1::NCBIGene:4779	8
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	cnc::FlyBase:FBgn0262975_in 1 to 1 orthology relationship with_Nfe2::MGI:97308	16
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Nfe2::MGI:97308_enables_transcription regulatory region sequence-specific DNA binding::GO:0000976	16
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Pngl::FlyBase:FBgn0033050_has phenotype_lethal - all die before end of P-stage::FBcv:0002000	20
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	lethal - all die before end of P-stage::FBcv:0002000_has phenotype_TER94::FlyBase:FBgn0261014	20
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	VCP::NCBIGene:7415_enables_protein domain specific binding::GO:0019904	16
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	protein domain specific binding::GO:0019904_enables_NFE2L1::NCBIGene:4779	32
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Pngl::FlyBase:FBgn0033050_has phenotype_female sterile::FBcv:0000366	48
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	female sterile::FBcv:0000366_has phenotype_Egfr::FlyBase:FBgn0003731	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Egfr::FlyBase:FBgn0003731_in 1 to 1 orthology relationship with_EGFR::NCBIGene:1956	36
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	EGFR::NCBIGene:1956_is part of_endoplasmic reticulum membrane::GO:0005789	36
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Drosophila embryo phenotype::FBbt:00000052PHENOTYPE_has phenotype_Jra::FlyBase:FBgn0001291	24
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Pngl::FlyBase:FBgn0033050_has phenotype_Drosophila pretarsus phenotype::FBbt:00004653PHENOTYPE	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Drosophila pretarsus phenotype::FBbt:00004653PHENOTYPE_has phenotype_Egfr::FlyBase:FBgn0003731	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Pngl::FlyBase:FBgn0033050_has phenotype_developmental rate defective::FBcv:0000450	24
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	developmental rate defective::FBcv:0000450_has phenotype_Egfr::FlyBase:FBgn0003731	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	male sterile::FBcv:0000370_has phenotype_TER94::FlyBase:FBgn0261014	20
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	short lived::FBcv:0000385_has phenotype_Egfr::FlyBase:FBgn0003731	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	nfe2::ZFIN:ZDB-GENE-030124-1_involved in_cellular response to oxidative stress::GO:0034599	16
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	cellular response to oxidative stress::GO:0034599_involved in_NFE2L1::NCBIGene:4779	16
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	developmental rate defective::FBcv:0000450_has phenotype_cnc::FlyBase:FBgn0262975	16
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	wing vein phenotype::FBbt:00004751PHENOTYPE_has phenotype_Stat92E::FlyBase:FBgn0016917	8
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	stat5a::ZFIN:ZDB-GENE-030820-2_None_erythrocyte differentiation::GO:0030218	16
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	short lived::FBcv:0000385_has phenotype_TER94::FlyBase:FBgn0261014	20
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	TER94::FlyBase:FBgn0261014_in 1 to 1 orthology relationship with_Vcp::MGI:99919	48
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Vcp::MGI:99919_enables_protein complex binding::GO:0032403	16
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	female sterile::FBcv:0000366_has phenotype_Atf6::FlyBase:FBgn0033010	12
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Atf6::FlyBase:FBgn0033010_in 1 to 1 orthology relationship with_Creb3::MGI:99946	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Creb3::MGI:99946_is part of_endoplasmic reticulum membrane::GO:0005789	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Vcp::MGI:99919_enables_protein domain specific binding::GO:0019904	16
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	male sterile::FBcv:0000370_has phenotype_RpS27A::FlyBase:FBgn0003942	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	RpS27A::FlyBase:FBgn0003942_in 1 to 1 orthology relationship with_RPS27A::NCBIGene:6233	16
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	RPS27A::NCBIGene:6233_is part of_endoplasmic reticulum membrane::GO:0005789	16
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	female sterile::FBcv:0000366_has phenotype_RpS27A::FlyBase:FBgn0003942	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Jra::FlyBase:FBgn0001291_in 1 to 1 orthology relationship with_Jun::RGD:2943	8
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Jun::RGD:2943_None_RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980	8
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	female sterile::FBcv:0000366_has phenotype_cnc::FlyBase:FBgn0262975	16
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	female sterile::FBcv:0000366_has phenotype_Stat92E::FlyBase:FBgn0016917	8
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Atf6::FlyBase:FBgn0033010_in 1 to 1 orthology relationship with_CREB3::NCBIGene:10488	8
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	CREB3::NCBIGene:10488_involved in_transcription from RNA polymerase II promoter::GO:0006366	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	male sterile::FBcv:0000370_has phenotype_Stat92E::FlyBase:FBgn0016917	8
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Vcp::MGI:99919_is part of_endoplasmic reticulum membrane::GO:0005789	16
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	short lived::FBcv:0000385_has phenotype_RpS27A::FlyBase:FBgn0003942	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	partially lethal - majority die::FBcv:0000352_has phenotype_Egfr::FlyBase:FBgn0003731	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	developmental rate defective::FBcv:0000450_has phenotype_Sec8::FlyBase:FBgn0266672	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Sec8::FlyBase:FBgn0266672_in 1 to 1 orthology relationship with_Exoc4::MGI:1096376	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Exoc4::MGI:1096376_enables_protein complex binding::GO:0032403	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	female sterile::FBcv:0000366_has phenotype_Hcf::FlyBase:FBgn0039904	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Hcf::FlyBase:FBgn0039904_in 1 to 1 orthology relationship with_HCFC1::NCBIGene:3054	12
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	HCFC1::NCBIGene:3054_involved in_transcription from RNA polymerase II promoter::GO:0006366	12
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	male sterile::FBcv:0000370_has phenotype_sinah::FlyBase:FBgn0259794	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	sinah::FlyBase:FBgn0259794_in 1 to 1 orthology relationship with_SIAH1::NCBIGene:6477	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	SIAH1::NCBIGene:6477_involved in_anatomical structure morphogenesis::GO:0009653	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	anatomical structure morphogenesis::GO:0009653_involved in_NFE2L1::NCBIGene:4779	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	partially lethal - majority die::FBcv:0000352_has phenotype_RpS27A::FlyBase:FBgn0003942	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Jun::MGI:96646_None_RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980	8
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Pngl::FlyBase:FBgn0033050_has phenotype_wing margin phenotype::FBbt:00005378PHENOTYPE	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	wing margin phenotype::FBbt:00005378PHENOTYPE_has phenotype_Egfr::FlyBase:FBgn0003731	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Drosophila embryo phenotype::FBbt:00000052PHENOTYPE_has phenotype_Egfr::FlyBase:FBgn0003731	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Jun::MGI:96646_involved in_transcription from RNA polymerase II promoter::GO:0006366	8
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	wing vein phenotype::FBbt:00004751PHENOTYPE_has phenotype_Egfr::FlyBase:FBgn0003731	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Pngl::FlyBase:FBgn0033050_has phenotype_Drosophila tarsal segment 4 phenotype::FBbt:00004651PHENOTYPE	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Drosophila tarsal segment 4 phenotype::FBbt:00004651PHENOTYPE_has phenotype_Egfr::FlyBase:FBgn0003731	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	CG3815::FlyBase:FBgn0029861_in 1 to 1 orthology relationship with_phf12b::ZFIN:ZDB-GENE-110628-2	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	phf12b::ZFIN:ZDB-GENE-110628-2_enables_transcription cofactor activity::GO:0003712	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	CREB3::NCBIGene:10488_is part of_endoplasmic reticulum membrane::GO:0005789	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	partially lethal - majority die::FBcv:0000352_has phenotype_Hcf::FlyBase:FBgn0039904	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	NGLY1::NCBIGene:55768_in 1 to 1 orthology relationship with_Ngly1::MGI:1913276	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Ngly1::MGI:1913276_has phenotype_Abnormality of cell physiology::HP:0011017	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Abnormality of cell physiology::HP:0011017_has phenotype_Traf2::MGI:101835	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	Traf2::MGI:101835_in 1 to 1 orthology relationship with_TRAF2::NCBIGene:7186	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	TRAF2::NCBIGene:7186_enables_protein complex binding::GO:0032403	4
NGLY1::NCBIGene:55768	NFE2L1::NCBIGene:4779	324	wing vein phenotype::FBbt:00004751PHENOTYPE_has phenotype_Hcf::FlyBase:FBgn0039904	4
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	NGLY1::NCBIGene:55768_in 1 to 1 orthology relationship with_Pngl::FlyBase:FBgn0033050	72
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	Pngl::FlyBase:FBgn0033050_has phenotype_short lived::FBcv:0000385	8
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	short lived::FBcv:0000385_has phenotype_RpS27A::FlyBase:FBgn0003942	4
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	RpS27A::FlyBase:FBgn0003942_in 1 to 1 orthology relationship with_RPS27A::NCBIGene:6233	16
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	RPS27A::NCBIGene:6233_involved in_protein folding::GO:0006457	16
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	protein folding::GO:0006457_involved in_ENGASE::NCBIGene:64772	48
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	Pngl::FlyBase:FBgn0033050_has phenotype_male sterile::FBcv:0000370	20
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	male sterile::FBcv:0000370_has phenotype_Rpt2::FlyBase:FBgn0015282	4
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	Rpt2::FlyBase:FBgn0015282_in 1 to 1 orthology relationship with_PSMC1::NCBIGene:5700	4
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	PSMC1::NCBIGene:5700_involved in_protein folding::GO:0006457	4
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	Pngl::FlyBase:FBgn0033050_has phenotype_Drosophila embryo phenotype::FBbt:00000052PHENOTYPE	4
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	Drosophila embryo phenotype::FBbt:00000052PHENOTYPE_has phenotype_TER94::FlyBase:FBgn0261014	4
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	TER94::FlyBase:FBgn0261014_in 1 to 1 orthology relationship with_VCP::NCBIGene:7415	16
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	VCP::NCBIGene:7415_involved in_protein folding::GO:0006457	16
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	Pngl::FlyBase:FBgn0033050_has phenotype_partially lethal - majority live::FBcv:0000350	4
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	partially lethal - majority live::FBcv:0000350_has phenotype_CG10694::FlyBase:FBgn0039147	4
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	CG10694::FlyBase:FBgn0039147_in 1 to 1 orthology relationship with_RAD23B::NCBIGene:5887	4
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	RAD23B::NCBIGene:5887_involved in_protein folding::GO:0006457	4
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	Pngl::FlyBase:FBgn0033050_has phenotype_female sterile::FBcv:0000366	12
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	female sterile::FBcv:0000366_has phenotype_RpS27A::FlyBase:FBgn0003942	4
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	Pngl::FlyBase:FBgn0033050_has phenotype_partially lethal - majority die::FBcv:0000352	16
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	partially lethal - majority die::FBcv:0000352_has phenotype_RpL40::FlyBase:FBgn0003941	4
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	RpL40::FlyBase:FBgn0003941_in 1 to 1 orthology relationship with_UBA52::NCBIGene:7311	4
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	UBA52::NCBIGene:7311_involved in_protein folding::GO:0006457	4
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	partially lethal - majority die::FBcv:0000352_has phenotype_CG18278::FlyBase:FBgn0033836	8
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	CG18278::FlyBase:FBgn0033836_in 1 to 1 orthology relationship with_gnsa::ZFIN:ZDB-GENE-050107-5	12
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	gnsa::ZFIN:ZDB-GENE-050107-5_is part of_lysosome::GO:0005764	12
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	lysosome::GO:0005764_is part of_ENGASE::NCBIGene:64772	24
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	Pngl::FlyBase:FBgn0033050_has phenotype_lethal - all die before end of P-stage::FBcv:0002000	4
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	lethal - all die before end of P-stage::FBcv:0002000_has phenotype_TER94::FlyBase:FBgn0261014	4
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	Pngl::FlyBase:FBgn0033050_has phenotype_wing vein phenotype::FBbt:00004751PHENOTYPE	4
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	wing vein phenotype::FBbt:00004751PHENOTYPE_has phenotype_Ubi-p5E::FlyBase:FBgn0086558	4
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	Ubi-p5E::FlyBase:FBgn0086558_in 1 to 1 orthology relationship with_UBC::NCBIGene:7316	4
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	UBC::NCBIGene:7316_involved in_protein folding::GO:0006457	4
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	short lived::FBcv:0000385_has phenotype_TER94::FlyBase:FBgn0261014	4
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	male sterile::FBcv:0000370_has phenotype_CG18278::FlyBase:FBgn0033836	8
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	male sterile::FBcv:0000370_has phenotype_RpS27A::FlyBase:FBgn0003942	4
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	male sterile::FBcv:0000370_has phenotype_TER94::FlyBase:FBgn0261014	4
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	female sterile::FBcv:0000366_has phenotype_CG18278::FlyBase:FBgn0033836	8
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	CG18278::FlyBase:FBgn0033836_in 1 to 1 orthology relationship with_Gns::MGI:1922862	12
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	Gns::MGI:1922862_is part of_lysosome::GO:0005764	12
NGLY1::NCBIGene:55768	ENGASE::NCBIGene:64772	72	partially lethal - majority die::FBcv:0000352_has phenotype_RpS27A::FlyBase:FBgn0003942	4
NGLY1::NCBIGene:55768	AQP3::NCBIGene:360	144	NGLY1::NCBIGene:55768_in 1 to 1 orthology relationship with_Pngl::FlyBase:FBgn0033050	144
NGLY1::NCBIGene:55768	AQP3::NCBIGene:360	144	Pngl::FlyBase:FBgn0033050_has phenotype_Drosophila embryo phenotype::FBbt:00000052PHENOTYPE	16
NGLY1::NCBIGene:55768	AQP3::NCBIGene:360	144	Drosophila embryo phenotype::FBbt:00000052PHENOTYPE_has phenotype_Egfr::FlyBase:FBgn0003731	16
NGLY1::NCBIGene:55768	AQP3::NCBIGene:360	144	Egfr::FlyBase:FBgn0003731_in 1 to 1 orthology relationship with_Egfr::MGI:95294	72
NGLY1::NCBIGene:55768	AQP3::NCBIGene:360	144	Egfr::MGI:95294_involved in_response to calcium ion::GO:0051592	36
NGLY1::NCBIGene:55768	AQP3::NCBIGene:360	144	response to calcium ion::GO:0051592_involved in_AQP3::NCBIGene:360	144
NGLY1::NCBIGene:55768	AQP3::NCBIGene:360	144	Pngl::FlyBase:FBgn0033050_has phenotype_wing margin phenotype::FBbt:00005378PHENOTYPE	16
NGLY1::NCBIGene:55768	AQP3::NCBIGene:360	144	wing margin phenotype::FBbt:00005378PHENOTYPE_has phenotype_Egfr::FlyBase:FBgn0003731	16
NGLY1::NCBIGene:55768	AQP3::NCBIGene:360	144	Pngl::FlyBase:FBgn0033050_has phenotype_Drosophila pretarsus phenotype::FBbt:00004653PHENOTYPE	16
NGLY1::NCBIGene:55768	AQP3::NCBIGene:360	144	Drosophila pretarsus phenotype::FBbt:00004653PHENOTYPE_has phenotype_Egfr::FlyBase:FBgn0003731	16
NGLY1::NCBIGene:55768	AQP3::NCBIGene:360	144	Egfr::FlyBase:FBgn0003731_in 1 to 1 orthology relationship with_EGFR::NCBIGene:1956	36
NGLY1::NCBIGene:55768	AQP3::NCBIGene:360	144	EGFR::NCBIGene:1956_involved in_response to calcium ion::GO:0051592	36
NGLY1::NCBIGene:55768	AQP3::NCBIGene:360	144	Pngl::FlyBase:FBgn0033050_has phenotype_developmental rate defective::FBcv:0000450	16
NGLY1::NCBIGene:55768	AQP3::NCBIGene:360	144	developmental rate defective::FBcv:0000450_has phenotype_Egfr::FlyBase:FBgn0003731	16
NGLY1::NCBIGene:55768	AQP3::NCBIGene:360	144	Egfr::MGI:95294_None_response to calcium ion::GO:0051592	36
NGLY1::NCBIGene:55768	AQP3::NCBIGene:360	144	Pngl::FlyBase:FBgn0033050_has phenotype_female sterile::FBcv:0000366	16
NGLY1::NCBIGene:55768	AQP3::NCBIGene:360	144	female sterile::FBcv:0000366_has phenotype_Egfr::FlyBase:FBgn0003731	16
NGLY1::NCBIGene:55768	AQP3::NCBIGene:360	144	Egfr::FlyBase:FBgn0003731_in 1 to 1 orthology relationship with_Egfr::RGD:2543	36
NGLY1::NCBIGene:55768	AQP3::NCBIGene:360	144	Egfr::RGD:2543_None_response to calcium ion::GO:0051592	36
NGLY1::NCBIGene:55768	AQP3::NCBIGene:360	144	Pngl::FlyBase:FBgn0033050_has phenotype_wing vein phenotype::FBbt:00004751PHENOTYPE	16
NGLY1::NCBIGene:55768	AQP3::NCBIGene:360	144	wing vein phenotype::FBbt:00004751PHENOTYPE_has phenotype_Egfr::FlyBase:FBgn0003731	16
NGLY1::NCBIGene:55768	AQP3::NCBIGene:360	144	Pngl::FlyBase:FBgn0033050_has phenotype_partially lethal - majority die::FBcv:0000352	16
NGLY1::NCBIGene:55768	AQP3::NCBIGene:360	144	partially lethal - majority die::FBcv:0000352_has phenotype_Egfr::FlyBase:FBgn0003731	16
NGLY1::NCBIGene:55768	AQP3::NCBIGene:360	144	Pngl::FlyBase:FBgn0033050_has phenotype_Drosophila tarsal segment 4 phenotype::FBbt:00004651PHENOTYPE	16
NGLY1::NCBIGene:55768	AQP3::NCBIGene:360	144	Drosophila tarsal segment 4 phenotype::FBbt:00004651PHENOTYPE_has phenotype_Egfr::FlyBase:FBgn0003731	16
NGLY1::NCBIGene:55768	AQP3::NCBIGene:360	144	Pngl::FlyBase:FBgn0033050_has phenotype_short lived::FBcv:0000385	16
NGLY1::NCBIGene:55768	AQP3::NCBIGene:360	144	short lived::FBcv:0000385_has phenotype_Egfr::FlyBase:FBgn0003731	16
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	NGLY1::NCBIGene:55768_in 1 to 1 orthology relationship with_Pngl::FlyBase:FBgn0033050	168
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	Pngl::FlyBase:FBgn0033050_has phenotype_short lived::FBcv:0000385	20
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	short lived::FBcv:0000385_has phenotype_TER94::FlyBase:FBgn0261014	8
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	TER94::FlyBase:FBgn0261014_in 1 to 1 orthology relationship with_Vcp::MGI:99919	16
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	Vcp::MGI:99919_involved in_protein homooligomerization::GO:0051260	16
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	protein homooligomerization::GO:0051260_involved in_AQP11::NCBIGene:282679	48
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	Pngl::FlyBase:FBgn0033050_has phenotype_female sterile::FBcv:0000366	20
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	female sterile::FBcv:0000366_has phenotype_Egfr::FlyBase:FBgn0003731	8
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	Egfr::FlyBase:FBgn0003731_in 1 to 1 orthology relationship with_EGFR::NCBIGene:1956	36
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	EGFR::NCBIGene:1956_is part of_cell surface::GO:0009986	36
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	cell surface::GO:0009986_is part of_AQP11::NCBIGene:282679	72
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	Pngl::FlyBase:FBgn0033050_has phenotype_Drosophila embryo phenotype::FBbt:00000052PHENOTYPE	20
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	Drosophila embryo phenotype::FBbt:00000052PHENOTYPE_has phenotype_TER94::FlyBase:FBgn0261014	8
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	Pngl::FlyBase:FBgn0033050_has phenotype_partially lethal - majority live::FBcv:0000350	4
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	partially lethal - majority live::FBcv:0000350_has phenotype_beta4GalNAcTA::FlyBase:FBgn0027538	4
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	beta4GalNAcTA::FlyBase:FBgn0027538_in 1 to 1 orthology relationship with_B4GALT1::NCBIGene:2683	12
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	B4GALT1::NCBIGene:2683_involved in_protein homooligomerization::GO:0051260	12
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	short lived::FBcv:0000385_has phenotype_Egfr::FlyBase:FBgn0003731	8
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	Egfr::FlyBase:FBgn0003731_in 1 to 1 orthology relationship with_Egfr::MGI:95294	36
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	Egfr::MGI:95294_is part of_cell surface::GO:0009986	36
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	Pngl::FlyBase:FBgn0033050_has phenotype_male sterile::FBcv:0000370	12
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	male sterile::FBcv:0000370_has phenotype_TER94::FlyBase:FBgn0261014	8
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	TER94::FlyBase:FBgn0261014_in 1 to 1 orthology relationship with_VCP::NCBIGene:7415	16
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	VCP::NCBIGene:7415_involved in_protein homooligomerization::GO:0051260	16
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	Pngl::FlyBase:FBgn0033050_has phenotype_developmental rate defective::FBcv:0000450	12
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	developmental rate defective::FBcv:0000450_has phenotype_Egfr::FlyBase:FBgn0003731	8
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	Pngl::FlyBase:FBgn0033050_has phenotype_Drosophila pretarsus phenotype::FBbt:00004653PHENOTYPE	8
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	Drosophila pretarsus phenotype::FBbt:00004653PHENOTYPE_has phenotype_Egfr::FlyBase:FBgn0003731	8
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	Pngl::FlyBase:FBgn0033050_has phenotype_wing margin phenotype::FBbt:00005378PHENOTYPE	8
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	wing margin phenotype::FBbt:00005378PHENOTYPE_has phenotype_Egfr::FlyBase:FBgn0003731	8
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	Pngl::FlyBase:FBgn0033050_has phenotype_Drosophila tarsal segment 4 phenotype::FBbt:00004651PHENOTYPE	8
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	Drosophila tarsal segment 4 phenotype::FBbt:00004651PHENOTYPE_has phenotype_Egfr::FlyBase:FBgn0003731	8
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	Pngl::FlyBase:FBgn0033050_has phenotype_wing vein phenotype::FBbt:00004751PHENOTYPE	20
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	wing vein phenotype::FBbt:00004751PHENOTYPE_has phenotype_Hcf::FlyBase:FBgn0039904	8
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	Hcf::FlyBase:FBgn0039904_in 1 to 1 orthology relationship with_HCFC1::NCBIGene:3054	12
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	HCFC1::NCBIGene:3054_is part of_dendrite::GO:0030425	12
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	dendrite::GO:0030425_is part of_AQP11::NCBIGene:282679	48
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	Pngl::FlyBase:FBgn0033050_has phenotype_partially lethal - majority die::FBcv:0000352	16
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	partially lethal - majority die::FBcv:0000352_has phenotype_Hcf::FlyBase:FBgn0039904	8
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	Pngl::FlyBase:FBgn0033050_has phenotype_some die during pharate adult stage::FBcv:0002038	4
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	some die during pharate adult stage::FBcv:0002038_has phenotype_sgg::FlyBase:FBgn0003371	4
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	sgg::FlyBase:FBgn0003371_in 1 to 1 orthology relationship with_Gsk3b::MGI:1861437	24
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	Gsk3b::MGI:1861437_is part of_dendrite::GO:0030425	24
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	Hcf::FlyBase:FBgn0039904_in 1 to 1 orthology relationship with_Hcfc1::MGI:105942	12
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	Hcfc1::MGI:105942_is part of_dendrite::GO:0030425	12
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	male sterile::FBcv:0000370_has phenotype_beta4GalNAcTA::FlyBase:FBgn0027538	4
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	wing vein phenotype::FBbt:00004751PHENOTYPE_has phenotype_Egfr::FlyBase:FBgn0003731	8
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	female sterile::FBcv:0000366_has phenotype_beta4GalNAcTA::FlyBase:FBgn0027538	4
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	Drosophila embryo phenotype::FBbt:00000052PHENOTYPE_has phenotype_sgg::FlyBase:FBgn0003371	4
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	partially lethal - majority die::FBcv:0000352_has phenotype_Egfr::FlyBase:FBgn0003731	8
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	wing vein phenotype::FBbt:00004751PHENOTYPE_has phenotype_sgg::FlyBase:FBgn0003371	4
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	short lived::FBcv:0000385_has phenotype_inc::FlyBase:FBgn0025394	4
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	inc::FlyBase:FBgn0025394_in 1 to 1 orthology relationship with_kctd5a::ZFIN:ZDB-GENE-030131-727	4
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	kctd5a::ZFIN:ZDB-GENE-030131-727_involved in_protein homooligomerization::GO:0051260	4
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	Drosophila embryo phenotype::FBbt:00000052PHENOTYPE_has phenotype_Egfr::FlyBase:FBgn0003731	8
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	Pngl::FlyBase:FBgn0033050_has phenotype_lethal - all die before end of P-stage::FBcv:0002000	12
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	lethal - all die before end of P-stage::FBcv:0002000_has phenotype_sgg::FlyBase:FBgn0003371	4
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	female sterile::FBcv:0000366_has phenotype_Hcf::FlyBase:FBgn0039904	8
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	lethal - all die before end of P-stage::FBcv:0002000_has phenotype_TER94::FlyBase:FBgn0261014	8
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	Pngl::FlyBase:FBgn0033050_has phenotype_Drosophila wing blade phenotype::FBbt:00006015PHENOTYPE	4
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	Drosophila wing blade phenotype::FBbt:00006015PHENOTYPE_has phenotype_sgg::FlyBase:FBgn0003371	4
NGLY1::NCBIGene:55768	AQP11::NCBIGene:282679	168	developmental rate defective::FBcv:0000450_has phenotype_sgg::FlyBase:FBgn0003371	4
AQP1::NCBIGene:358	NGLY1::NCBIGene:55768	16	AQP1::NCBIGene:358_in 1 to 1 orthology relationship with_Aqp1::MGI:103201	16
AQP1::NCBIGene:358	NGLY1::NCBIGene:55768	16	Aqp1::MGI:103201_has phenotype_behavior/neurological phenotype::MP:0005386	8
AQP1::NCBIGene:358	NGLY1::NCBIGene:55768	16	behavior/neurological phenotype::MP:0005386_has phenotype_Vcp::MGI:99919	8
AQP1::NCBIGene:358	NGLY1::NCBIGene:55768	16	Vcp::MGI:99919_in 1 to 1 orthology relationship with_VCP::NCBIGene:7415	16
AQP1::NCBIGene:358	NGLY1::NCBIGene:55768	16	VCP::NCBIGene:7415_Source_Deglycosylation complex hydrolyses N-glycans from unfolded glycoproteins::REACT:R-HSA-8850594	8
AQP1::NCBIGene:358	NGLY1::NCBIGene:55768	16	Deglycosylation complex hydrolyses N-glycans from unfolded glycoproteins::REACT:R-HSA-8850594_Source_NGLY1::NCBIGene:55768	8
AQP1::NCBIGene:358	NGLY1::NCBIGene:55768	16	Aqp1::MGI:103201_has phenotype_decreased grip strength::MP:0010053	8
AQP1::NCBIGene:358	NGLY1::NCBIGene:55768	16	decreased grip strength::MP:0010053_has phenotype_Vcp::MGI:99919	8
AQP1::NCBIGene:358	NGLY1::NCBIGene:55768	16	VCP::NCBIGene:7415_involved in_protein folding::GO:0006457	8
AQP1::NCBIGene:358	NGLY1::NCBIGene:55768	16	protein folding::GO:0006457_involved in_NGLY1::NCBIGene:55768	8
AQP1::NCBIGene:358	Aqp1::NCBIGene:11826	0	NA	0
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	AQP1::NCBIGene:358_in 1 to 1 orthology relationship with_Aqp1::MGI:103201	172
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Aqp1::MGI:103201_has phenotype_Behavioral abnormality::HP:0000708	56
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Behavioral abnormality::HP:0000708_has phenotype_Nfe2l2::MGI:108420	36
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Nfe2l2::MGI:108420_in 1 to 1 orthology relationship with_nfe2l2a::ZFIN:ZDB-GENE-030723-2	16
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	nfe2l2a::ZFIN:ZDB-GENE-030723-2_enables_transcription regulatory region sequence-specific DNA binding::GO:0000976	8
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	transcription regulatory region sequence-specific DNA binding::GO:0000976_enables_NFE2L1::NCBIGene:4779	16
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Behavioral abnormality::HP:0000708_has phenotype_VCP::NCBIGene:7415	12
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	VCP::NCBIGene:7415_in 1 to 1 orthology relationship with_Vcp::MGI:99919	12
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Vcp::MGI:99919_enables_protein complex binding::GO:0032403	4
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	protein complex binding::GO:0032403_enables_NFE2L1::NCBIGene:4779	4
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Aqp1::MGI:103201_has phenotype_Functional respiratory abnormality::HP:0002795	36
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Functional respiratory abnormality::HP:0002795_has phenotype_Nfe2l2::MGI:108420	36
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Nfe2l2::MGI:108420_in 1 to 1 orthology relationship with_NFE2L2::NCBIGene:4780	48
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	NFE2L2::NCBIGene:4780_enables_protein domain specific binding::GO:0019904	8
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	protein domain specific binding::GO:0019904_enables_NFE2L1::NCBIGene:4779	20
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Behavioral abnormality::HP:0000708_has phenotype_Fos::MGI:95574	8
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Fos::MGI:95574_in 1 to 1 orthology relationship with_FOS::NCBIGene:2353	16
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	FOS::NCBIGene:2353_involved in_transcription from RNA polymerase II promoter::GO:0006366	8
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	transcription from RNA polymerase II promoter::GO:0006366_involved in_NFE2L1::NCBIGene:4779	28
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Aqp1::MGI:103201_has phenotype_nervous system phenotype::MP:0003631	16
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	nervous system phenotype::MP:0003631_has phenotype_Jun::MGI:96646	12
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Jun::MGI:96646_in 1 to 1 orthology relationship with_Jun::RGD:2943	4
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Jun::RGD:2943_None_RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980	4
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980_enables_NFE2L1::NCBIGene:4779	40
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	NFE2L2::NCBIGene:4780_involved in_cellular response to oxidative stress::GO:0034599	8
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	cellular response to oxidative stress::GO:0034599_involved in_NFE2L1::NCBIGene:4779	16
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	NFE2L2::NCBIGene:4780_enables_RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980	8
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	NFE2L2::NCBIGene:4780_involved in_transcription from RNA polymerase II promoter::GO:0006366	8
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	NFE2L2::NCBIGene:4780_enables_transcription regulatory region sequence-specific DNA binding::GO:0000976	8
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	NFE2L2::NCBIGene:4780_involved in_inflammatory response::GO:0006954	8
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	inflammatory response::GO:0006954_involved in_NFE2L1::NCBIGene:4779	16
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Aqp1::MGI:103201_has phenotype_behavior/neurological phenotype::MP:0005386	16
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	behavior/neurological phenotype::MP:0005386_has phenotype_Fos::MGI:95574	8
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	FOS::NCBIGene:2353_involved in_inflammatory response::GO:0006954	8
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Aqp1::MGI:103201_has phenotype_decreased bone mineral content::MP:0010124	24
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	decreased bone mineral content::MP:0010124_has phenotype_Bach2::MGI:894679	24
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Bach2::MGI:894679_in 1 to 1 orthology relationship with_BACH2::NCBIGene:60468	8
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	BACH2::NCBIGene:60468_enables_RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980	4
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Jun::MGI:96646_in 1 to 1 orthology relationship with_JUN::NCBIGene:3725	8
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	JUN::NCBIGene:3725_enables_RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980	4
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Vcp::MGI:99919_is part of_endoplasmic reticulum membrane::GO:0005789	4
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	endoplasmic reticulum membrane::GO:0005789_is part of_NFE2L1::NCBIGene:4779	32
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Bach2::MGI:894679_in 1 to 1 orthology relationship with_Bach2::RGD:1562865	4
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Bach2::RGD:1562865_None_RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980	4
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	JUN::NCBIGene:3725_involved in_transcription from RNA polymerase II promoter::GO:0006366	4
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	BACH2::NCBIGene:60468_involved in_transcription from RNA polymerase II promoter::GO:0006366	4
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Bach2::MGI:894679_in 1 to 1 orthology relationship with_bach2b::ZFIN:ZDB-GENE-041001-139	12
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	bach2b::ZFIN:ZDB-GENE-041001-139_None_RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980	4
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	nervous system phenotype::MP:0003631_has phenotype_Egfr::MGI:95294	4
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Egfr::MGI:95294_in 1 to 1 orthology relationship with_EGFR::NCBIGene:1956	12
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	EGFR::NCBIGene:1956_is part of_endoplasmic reticulum membrane::GO:0005789	12
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Aqp1::MGI:103201_has phenotype_endocrine/exocrine gland phenotype::MP:0005379	4
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	endocrine/exocrine gland phenotype::MP:0005379_has phenotype_Egfr::MGI:95294	4
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Aqp1::MGI:103201_has phenotype_decreased grip strength::MP:0010053	12
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	decreased grip strength::MP:0010053_has phenotype_Vcp::MGI:99919	8
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Vcp::MGI:99919_in 1 to 1 orthology relationship with_VCP::NCBIGene:7415	16
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	VCP::NCBIGene:7415_enables_protein domain specific binding::GO:0019904	8
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Nfe2l2::MGI:108420_in 1 to 1 orthology relationship with_Nfe2l2::RGD:620360	8
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Nfe2l2::RGD:620360_None_RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980	8
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Aqp1::MGI:103201_has phenotype_hypoactivity::MP:0001402	4
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	hypoactivity::MP:0001402_has phenotype_Cav1::MGI:102709	4
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Cav1::MGI:102709_in 1 to 1 orthology relationship with_CAV1::NCBIGene:857	8
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	CAV1::NCBIGene:857_is part of_endoplasmic reticulum membrane::GO:0005789	8
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	nfe2l2a::ZFIN:ZDB-GENE-030723-2_involved in_cellular response to oxidative stress::GO:0034599	8
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	bach2b::ZFIN:ZDB-GENE-041001-139_involved in_transcription from RNA polymerase II promoter::GO:0006366	4
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Aqp1::MGI:103201_has phenotype_Dehydration::HP:0001944	4
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Dehydration::HP:0001944_has phenotype_Egfr::MGI:95294	4
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	VCP::NCBIGene:7415_is part of_endoplasmic reticulum membrane::GO:0005789	8
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	Vcp::MGI:99919_enables_protein domain specific binding::GO:0019904	4
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	decreased grip strength::MP:0010053_has phenotype_Cav1::MGI:102709	4
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	behavior/neurological phenotype::MP:0005386_has phenotype_Vcp::MGI:99919	8
AQP1::NCBIGene:358	NFE2L1::NCBIGene:4779	172	bach2b::ZFIN:ZDB-GENE-041001-139_enables_RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980	4
AQP1::NCBIGene:358	ENGASE::NCBIGene:64772	12	AQP1::NCBIGene:358_in 1 to 1 orthology relationship with_Aqp1::MGI:103201	12
AQP1::NCBIGene:358	ENGASE::NCBIGene:64772	12	Aqp1::MGI:103201_has phenotype_decreased grip strength::MP:0010053	4
AQP1::NCBIGene:358	ENGASE::NCBIGene:64772	12	decreased grip strength::MP:0010053_has phenotype_Vcp::MGI:99919	4
AQP1::NCBIGene:358	ENGASE::NCBIGene:64772	12	Vcp::MGI:99919_in 1 to 1 orthology relationship with_VCP::NCBIGene:7415	8
AQP1::NCBIGene:358	ENGASE::NCBIGene:64772	12	VCP::NCBIGene:7415_involved in_protein folding::GO:0006457	8
AQP1::NCBIGene:358	ENGASE::NCBIGene:64772	12	protein folding::GO:0006457_involved in_ENGASE::NCBIGene:64772	8
AQP1::NCBIGene:358	ENGASE::NCBIGene:64772	12	Aqp1::MGI:103201_has phenotype_behavior/neurological phenotype::MP:0005386	4
AQP1::NCBIGene:358	ENGASE::NCBIGene:64772	12	behavior/neurological phenotype::MP:0005386_has phenotype_Vcp::MGI:99919	4
AQP1::NCBIGene:358	ENGASE::NCBIGene:64772	12	Aqp1::MGI:103201_has phenotype_Dehydration::HP:0001944	4
AQP1::NCBIGene:358	ENGASE::NCBIGene:64772	12	Dehydration::HP:0001944_has phenotype_AQP2::NCBIGene:359	4
AQP1::NCBIGene:358	ENGASE::NCBIGene:64772	12	AQP2::NCBIGene:359_in 1 to 1 orthology relationship with_Aqp2::MGI:1096865	4
AQP1::NCBIGene:358	ENGASE::NCBIGene:64772	12	Aqp2::MGI:1096865_is part of_lysosome::GO:0005764	4
AQP1::NCBIGene:358	ENGASE::NCBIGene:64772	12	lysosome::GO:0005764_is part of_ENGASE::NCBIGene:64772	4
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	AQP1::NCBIGene:358_in 1 to 1 orthology relationship with_Aqp1::MGI:103201	532
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp1::MGI:103201_has phenotype_abnormal renal water transport::MP:0011443	40
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	abnormal renal water transport::MP:0011443_has phenotype_Aqp3::MGI:1333777	32
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp3::MGI:1333777_in 1 to 1 orthology relationship with_Aqp3::RGD:68428	256
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp3::RGD:68428_None_cellular response to hypoxia::GO:0071456	32
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	cellular response to hypoxia::GO:0071456_involved in_AQP3::NCBIGene:360	48
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp1::MGI:103201_has phenotype_endocrine/exocrine gland phenotype::MP:0005379	28
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	endocrine/exocrine gland phenotype::MP:0005379_has phenotype_Aqp5::MGI:106215	12
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp5::MGI:106215_in 1 to 1 orthology relationship with_Aqp5::RGD:2144	16
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp5::RGD:2144_None_odontogenesis::GO:0042476	16
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	odontogenesis::GO:0042476_involved in_AQP3::NCBIGene:360	64
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp1::MGI:103201_has phenotype_increased blood osmolality::MP:0008997	52
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	increased blood osmolality::MP:0008997_has phenotype_Aqp3::MGI:1333777	32
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp3::RGD:68428_None_odontogenesis::GO:0042476	32
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp1::MGI:103201_has phenotype_decreased bone mineral content::MP:0010124	32
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	decreased bone mineral content::MP:0010124_has phenotype_Aqp3::MGI:1333777	32
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp3::RGD:68428_None_cellular response to oxygen-glucose deprivation::GO:0090650	32
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	cellular response to oxygen-glucose deprivation::GO:0090650_involved in_AQP3::NCBIGene:360	32
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp1::MGI:103201_has phenotype_decreased urine osmolality::MP:0002988	72
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	decreased urine osmolality::MP:0002988_has phenotype_Aqp2::MGI:1096865	20
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp2::MGI:1096865_in 1 to 1 orthology relationship with_Aqp2::RGD:2142	32
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp2::RGD:2142_None_glycerol transport::GO:0015793	20
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	glycerol transport::GO:0015793_involved in_AQP3::NCBIGene:360	80
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp1::MGI:103201_has phenotype_vision/eye phenotype::MP:0005391	52
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	vision/eye phenotype::MP:0005391_has phenotype_Aqp5::MGI:106215	12
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp5::MGI:106215_in 1 to 1 orthology relationship with_AQP5::NCBIGene:362	32
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	AQP5::NCBIGene:362_involved in_excretion::GO:0007588	16
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	excretion::GO:0007588_involved in_AQP3::NCBIGene:360	32
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp1::MGI:103201_has phenotype_Functional respiratory abnormality::HP:0002795	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Functional respiratory abnormality::HP:0002795_has phenotype_Nfe2l2::MGI:108420	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Nfe2l2::MGI:108420_in 1 to 1 orthology relationship with_NFE2L2::NCBIGene:4780	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	NFE2L2::NCBIGene:4780_involved in_cellular response to hypoxia::GO:0071456	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp1::MGI:103201_has phenotype_Dehydration::HP:0001944	48
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Dehydration::HP:0001944_has phenotype_Aqp2::MGI:1096865	20
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp2::RGD:2142_None_response to calcium ion::GO:0051592	20
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	response to calcium ion::GO:0051592_involved in_AQP3::NCBIGene:360	72
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp2::MGI:1096865_in 1 to 1 orthology relationship with_AQP2::NCBIGene:359	48
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	AQP2::NCBIGene:359_involved in_glycerol transport::GO:0015793	16
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp1::MGI:103201_has phenotype_Behavioral abnormality::HP:0000708	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Behavioral abnormality::HP:0000708_has phenotype_Nfe2l2::MGI:108420	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Nfe2l2::MGI:108420_in 1 to 1 orthology relationship with_Nfe2l2::RGD:620360	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Nfe2l2::RGD:620360_None_cellular response to hypoxia::GO:0071456	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp3::RGD:68428_None_glycerol transport::GO:0015793	32
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp1::MGI:103201_has phenotype_hearing/vestibular/ear phenotype::MP:0005377	44
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	hearing/vestibular/ear phenotype::MP:0005377_has phenotype_Aqp5::MGI:106215	12
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	hearing/vestibular/ear phenotype::MP:0005377_has phenotype_Aqp3::MGI:1333777	32
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	increased blood osmolality::MP:0008997_has phenotype_Aqp2::MGI:1096865	20
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	AQP2::NCBIGene:359_involved in_excretion::GO:0007588	16
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp1::MGI:103201_has phenotype_Lethargy::HP:0001254	20
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Lethargy::HP:0001254_has phenotype_Aqp2::MGI:1096865	20
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	vision/eye phenotype::MP:0005391_has phenotype_Aqp3::MGI:1333777	32
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	AQP5::NCBIGene:362_involved in_odontogenesis::GO:0042476	16
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp1::MGI:103201_has phenotype_nervous system phenotype::MP:0003631	16
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	nervous system phenotype::MP:0003631_has phenotype_Aqp4::MGI:107387	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp4::MGI:107387_in 1 to 1 orthology relationship with_Aqp4::RGD:2143	24
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp4::RGD:2143_None_renal water absorption::GO:0070295	24
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	renal water absorption::GO:0070295_involved in_AQP3::NCBIGene:360	56
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp1::MGI:103201_has phenotype_Glucose intolerance::HP:0000833	12
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Glucose intolerance::HP:0000833_has phenotype_CAV1::NCBIGene:857	12
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	CAV1::NCBIGene:857_in 1 to 1 orthology relationship with_Cav1::MGI:102709	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Cav1::MGI:102709_involved in_response to calcium ion::GO:0051592	4
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp3::RGD:68428_None_urea transport::GO:0015840	32
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	urea transport::GO:0015840_involved in_AQP3::NCBIGene:360	36
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp1::MGI:103201_has phenotype_Elevated tissue non-specific alkaline phosphatase::HP:0010679	32
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Elevated tissue non-specific alkaline phosphatase::HP:0010679_has phenotype_Aqp3::MGI:1333777	32
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp3::RGD:68428_None_renal water absorption::GO:0070295	32
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp3::RGD:68428_None_glycerol channel activity::GO:0015254	32
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	glycerol channel activity::GO:0015254_enables_AQP3::NCBIGene:360	32
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp1::MGI:103201_has phenotype_decreased grip strength::MP:0010053	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	decreased grip strength::MP:0010053_has phenotype_Cav1::MGI:102709	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Cav1::MGI:102709_in 1 to 1 orthology relationship with_CAV1::NCBIGene:857	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	CAV1::NCBIGene:857_involved in_response to calcium ion::GO:0051592	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	AQP2::NCBIGene:359_involved in_renal water homeostasis::GO:0003091	16
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	renal water homeostasis::GO:0003091_involved in_AQP3::NCBIGene:360	48
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp1::MGI:103201_has phenotype_Hyperproteinemia::HP:0002152	32
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Hyperproteinemia::HP:0002152_has phenotype_Aqp3::MGI:1333777	32
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	nervous system phenotype::MP:0003631_has phenotype_Egfr::MGI:95294	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Egfr::MGI:95294_in 1 to 1 orthology relationship with_EGFR::NCBIGene:1956	12
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	EGFR::NCBIGene:1956_involved in_response to calcium ion::GO:0051592	12
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp1::MGI:103201_has phenotype_behavior/neurological phenotype::MP:0005386	20
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	behavior/neurological phenotype::MP:0005386_has phenotype_Aqp5::MGI:106215	12
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp1::MGI:103201_has phenotype_hypoactivity::MP:0001402	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	hypoactivity::MP:0001402_has phenotype_Cav1::MGI:102709	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Cav1::MGI:102709_in 1 to 1 orthology relationship with_Cav1::RGD:2280	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Cav1::RGD:2280_None_response to calcium ion::GO:0051592	12
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp3::RGD:68428_None_response to retinoic acid::GO:0032526	32
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	response to retinoic acid::GO:0032526_involved in_AQP3::NCBIGene:360	32
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Dehydration::HP:0001944_has phenotype_Avp::MGI:88121	4
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Avp::MGI:88121_in 1 to 1 orthology relationship with_AVP::NCBIGene:551	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	AVP::NCBIGene:551_involved in_renal water homeostasis::GO:0003091	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	decreased urine osmolality::MP:0002988_has phenotype_Aqp3::MGI:1333777	32
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	endocrine/exocrine gland phenotype::MP:0005379_has phenotype_Egfr::MGI:95294	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Egfr::MGI:95294_in 1 to 1 orthology relationship with_Egfr::RGD:2543	12
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Egfr::RGD:2543_None_response to calcium ion::GO:0051592	12
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	decreased urine osmolality::MP:0002988_has phenotype_Aqp4::MGI:107387	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	vision/eye phenotype::MP:0005391_has phenotype_Aqp4::MGI:107387	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Dehydration::HP:0001944_has phenotype_Egfr::MGI:95294	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	abnormal renal water transport::MP:0011443_has phenotype_Aqp4::MGI:107387	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp4::MGI:107387_in 1 to 1 orthology relationship with_AQP4::NCBIGene:361	24
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	AQP4::NCBIGene:361_involved in_renal water homeostasis::GO:0003091	24
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	decreased urine osmolality::MP:0002988_has phenotype_Avp::MGI:88121	4
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Dehydration::HP:0001944_has phenotype_AQP2::NCBIGene:359	16
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	AQP2::NCBIGene:359_in 1 to 1 orthology relationship with_Aqp2::MGI:1096865	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp2::MGI:1096865_None_glycerol transport::GO:0015793	4
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	AQP2::NCBIGene:359_in 1 to 1 orthology relationship with_Aqp2::RGD:2142	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	CAV1::NCBIGene:857_in 1 to 1 orthology relationship with_Cav1::RGD:2280	4
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	behavior/neurological phenotype::MP:0005386_has phenotype_Aqp4::MGI:107387	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	endocrine/exocrine gland phenotype::MP:0005379_has phenotype_Aqp4::MGI:107387	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Cav1::MGI:102709_None_response to calcium ion::GO:0051592	4
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp2::MGI:1096865_involved in_glycerol transport::GO:0015793	4
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	decreased urine osmolality::MP:0002988_has phenotype_Aqp11::MGI:1913583	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp11::MGI:1913583_in 1 to 1 orthology relationship with_Aqp11::RGD:628763	8
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp11::RGD:628763_None_glycerol transport::GO:0015793	4
AQP1::NCBIGene:358	AQP3::NCBIGene:360	532	Aqp11::RGD:628763_None_urea transport::GO:0015840	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	AQP1::NCBIGene:358_in 1 to 1 orthology relationship with_Aqp1::MGI:103201	64
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	Aqp1::MGI:103201_has phenotype_nervous system phenotype::MP:0003631	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	nervous system phenotype::MP:0003631_has phenotype_Egfr::MGI:95294	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	Egfr::MGI:95294_in 1 to 1 orthology relationship with_EGFR::NCBIGene:1956	12
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	EGFR::NCBIGene:1956_is part of_cell surface::GO:0009986	12
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	cell surface::GO:0009986_is part of_AQP11::NCBIGene:282679	20
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	Aqp1::MGI:103201_has phenotype_decreased urine osmolality::MP:0002988	12
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	decreased urine osmolality::MP:0002988_has phenotype_Aqp11::MGI:1913583	8
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	Aqp11::MGI:1913583_in 1 to 1 orthology relationship with_Aqp11::RGD:628763	8
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	Aqp11::RGD:628763_None_endosomal lumen acidification::GO:0048388	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	endosomal lumen acidification::GO:0048388_involved in_AQP11::NCBIGene:282679	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	Aqp1::MGI:103201_has phenotype_Behavioral abnormality::HP:0000708	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	Behavioral abnormality::HP:0000708_has phenotype_VCP::NCBIGene:7415	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	VCP::NCBIGene:7415_in 1 to 1 orthology relationship with_Vcp::MGI:99919	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	Vcp::MGI:99919_involved in_protein homooligomerization::GO:0051260	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	protein homooligomerization::GO:0051260_involved in_AQP11::NCBIGene:282679	24
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	Aqp1::MGI:103201_has phenotype_Glucose intolerance::HP:0000833	12
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	Glucose intolerance::HP:0000833_has phenotype_CAV1::NCBIGene:857	8
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	CAV1::NCBIGene:857_in 1 to 1 orthology relationship with_Cav1::MGI:102709	8
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	Cav1::MGI:102709_is part of_cell surface::GO:0009986	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	Aqp1::MGI:103201_has phenotype_Lethargy::HP:0001254	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	Lethargy::HP:0001254_has phenotype_AVP::NCBIGene:551	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	AVP::NCBIGene:551_in 1 to 1 orthology relationship with_Avp::MGI:88121	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	Avp::MGI:88121_is part of_dendrite::GO:0030425	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	dendrite::GO:0030425_is part of_AQP11::NCBIGene:282679	12
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	Aqp1::MGI:103201_has phenotype_Dehydration::HP:0001944	8
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	Dehydration::HP:0001944_has phenotype_Egfr::MGI:95294	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	Cav1::MGI:102709_involved in_protein homooligomerization::GO:0051260	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	Aqp1::MGI:103201_has phenotype_decreased grip strength::MP:0010053	8
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	decreased grip strength::MP:0010053_has phenotype_Vcp::MGI:99919	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	Vcp::MGI:99919_in 1 to 1 orthology relationship with_VCP::NCBIGene:7415	8
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	VCP::NCBIGene:7415_involved in_protein homooligomerization::GO:0051260	8
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	Dehydration::HP:0001944_has phenotype_Avp::MGI:88121	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	Avp::MGI:88121_in 1 to 1 orthology relationship with_AVP::NCBIGene:551	8
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	AVP::NCBIGene:551_is part of_dendrite::GO:0030425	8
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	Aqp1::MGI:103201_has phenotype_hypoactivity::MP:0001402	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	hypoactivity::MP:0001402_has phenotype_Cav1::MGI:102709	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	Cav1::MGI:102709_in 1 to 1 orthology relationship with_CAV1::NCBIGene:857	8
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	CAV1::NCBIGene:857_involved in_protein homooligomerization::GO:0051260	8
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	decreased urine osmolality::MP:0002988_has phenotype_Avp::MGI:88121	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	decreased grip strength::MP:0010053_has phenotype_Cav1::MGI:102709	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	Aqp1::MGI:103201_has phenotype_endocrine/exocrine gland phenotype::MP:0005379	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	endocrine/exocrine gland phenotype::MP:0005379_has phenotype_Egfr::MGI:95294	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	Aqp11::RGD:628763_None_proximal tubule development::GO:0072014	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	proximal tubule development::GO:0072014_involved in_AQP11::NCBIGene:282679	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	Glucose intolerance::HP:0000833_has phenotype_Stx4a::MGI:893577	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	Stx4a::MGI:893577_in 1 to 1 orthology relationship with_STX4::NCBIGene:6810	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	STX4::NCBIGene:6810_is part of_cell surface::GO:0009986	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	Aqp1::MGI:103201_has phenotype_behavior/neurological phenotype::MP:0005386	4
AQP1::NCBIGene:358	AQP11::NCBIGene:282679	64	behavior/neurological phenotype::MP:0005386_has phenotype_Vcp::MGI:99919	4
Aqp1::NCBIGene:11826	NGLY1::NCBIGene:55768	0	NA	0
Aqp1::NCBIGene:11826	AQP1::NCBIGene:358	0	NA	0
Aqp1::NCBIGene:11826	NFE2L1::NCBIGene:4779	0	NA	0
Aqp1::NCBIGene:11826	ENGASE::NCBIGene:64772	0	NA	0
Aqp1::NCBIGene:11826	AQP3::NCBIGene:360	0	NA	0
Aqp1::NCBIGene:11826	AQP11::NCBIGene:282679	0	NA	0
NFE2L1::NCBIGene:4779	NGLY1::NCBIGene:55768	32	NFE2L1::NCBIGene:4779_in 1 to 1 orthology relationship with_Nfe2l1::MGI:99421	32
NFE2L1::NCBIGene:4779	NGLY1::NCBIGene:55768	32	Nfe2l1::MGI:99421_has phenotype_embryonic growth retardation::MP:0003984	8
NFE2L1::NCBIGene:4779	NGLY1::NCBIGene:55768	32	embryonic growth retardation::MP:0003984_has phenotype_Derl1::MGI:1915069	8
NFE2L1::NCBIGene:4779	NGLY1::NCBIGene:55768	32	Derl1::MGI:1915069_in 1 to 1 orthology relationship with_DERL1::NCBIGene:79139	8
NFE2L1::NCBIGene:4779	NGLY1::NCBIGene:55768	32	DERL1::NCBIGene:79139_Source_Deglycosylation complex hydrolyses N-glycans from unfolded glycoproteins::REACT:R-HSA-8850594	4
NFE2L1::NCBIGene:4779	NGLY1::NCBIGene:55768	32	Deglycosylation complex hydrolyses N-glycans from unfolded glycoproteins::REACT:R-HSA-8850594_Source_NGLY1::NCBIGene:55768	16
NFE2L1::NCBIGene:4779	NGLY1::NCBIGene:55768	32	DERL1::NCBIGene:79139_involved in_protein folding::GO:0006457	4
NFE2L1::NCBIGene:4779	NGLY1::NCBIGene:55768	32	protein folding::GO:0006457_involved in_NGLY1::NCBIGene:55768	16
NFE2L1::NCBIGene:4779	NGLY1::NCBIGene:55768	32	Nfe2l1::MGI:99421_has phenotype_Hepatic steatosis::HP:0001397	8
NFE2L1::NCBIGene:4779	NGLY1::NCBIGene:55768	32	Hepatic steatosis::HP:0001397_has phenotype_Amfr::MGI:1345634	8
NFE2L1::NCBIGene:4779	NGLY1::NCBIGene:55768	32	Amfr::MGI:1345634_in 1 to 1 orthology relationship with_AMFR::NCBIGene:267	24
NFE2L1::NCBIGene:4779	NGLY1::NCBIGene:55768	32	AMFR::NCBIGene:267_Source_Deglycosylation complex hydrolyses N-glycans from unfolded glycoproteins::REACT:R-HSA-8850594	12
NFE2L1::NCBIGene:4779	NGLY1::NCBIGene:55768	32	Nfe2l1::MGI:99421_has phenotype_Hepatitis::HP:0012115	8
NFE2L1::NCBIGene:4779	NGLY1::NCBIGene:55768	32	Hepatitis::HP:0012115_has phenotype_Amfr::MGI:1345634	8
NFE2L1::NCBIGene:4779	NGLY1::NCBIGene:55768	32	AMFR::NCBIGene:267_involved in_protein folding::GO:0006457	12
NFE2L1::NCBIGene:4779	NGLY1::NCBIGene:55768	32	Nfe2l1::MGI:99421_has phenotype_Hepatic fibrosis::HP:0001395	8
NFE2L1::NCBIGene:4779	NGLY1::NCBIGene:55768	32	Hepatic fibrosis::HP:0001395_has phenotype_Amfr::MGI:1345634	8
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	NFE2L1::NCBIGene:4779_in 1 to 1 orthology relationship with_Nfe2l1::MGI:99421	992
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l1::MGI:99421_has phenotype_Hyperglycemia::HP:0003074	60
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Hyperglycemia::HP:0003074_has phenotype_CAV1::NCBIGene:857	40
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	CAV1::NCBIGene:857_in 1 to 1 orthology relationship with_Cav1::RGD:2280	60
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Cav1::RGD:2280_None_response to estrogen::GO:0043627	52
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	response to estrogen::GO:0043627_involved in_AQP1::NCBIGene:358	124
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l1::MGI:99421_has phenotype_Hepatocellular carcinoma::HP:0001402	28
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Hepatocellular carcinoma::HP:0001402_has phenotype_NFE2L2::NCBIGene:4780	28
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	NFE2L2::NCBIGene:4780_in 1 to 1 orthology relationship with_Nfe2l2::MGI:108420	80
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l2::MGI:108420_involved in_positive regulation of angiogenesis::GO:0045766	20
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	positive regulation of angiogenesis::GO:0045766_involved in_AQP1::NCBIGene:358	116
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l1::MGI:99421_has phenotype_Hepatic necrosis::HP:0002605	52
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Hepatic necrosis::HP:0002605_has phenotype_Jun::MGI:96646	24
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Jun::MGI:96646_in 1 to 1 orthology relationship with_Jun::RGD:2943	32
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Jun::RGD:2943_None_positive regulation of fibroblast proliferation::GO:0048146	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	positive regulation of fibroblast proliferation::GO:0048146_involved in_AQP1::NCBIGene:358	48
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l1::MGI:99421_has phenotype_growth/size/body region phenotype::MP:0005378	28
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	growth/size/body region phenotype::MP:0005378_has phenotype_Egfr::MGI:95294	24
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Egfr::MGI:95294_in 1 to 1 orthology relationship with_Egfr::RGD:2543	48
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Egfr::RGD:2543_None_cellular response to mechanical stimulus::GO:0071260	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	cellular response to mechanical stimulus::GO:0071260_involved in_AQP1::NCBIGene:358	124
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l1::MGI:99421_has phenotype_homeostasis/metabolism phenotype::MP:0005376	136
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Nfe2l2::MGI:108420	24
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l2::MGI:108420_in 1 to 1 orthology relationship with_Nfe2l2::RGD:620360	72
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l2::RGD:620360_None_cellular response to hypoxia::GO:0071456	44
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	cellular response to hypoxia::GO:0071456_involved in_AQP1::NCBIGene:358	68
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l1::MGI:99421_has phenotype_Abnormal glucose homeostasis::HP:0011014	28
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Abnormal glucose homeostasis::HP:0011014_has phenotype_Cav1::MGI:102709	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Cav1::MGI:102709_in 1 to 1 orthology relationship with_CAV1::NCBIGene:857	32
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	CAV1::NCBIGene:857_involved in_response to estrogen::GO:0043627	32
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Aqp4::MGI:107387	36
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Aqp4::MGI:107387_in 1 to 1 orthology relationship with_Aqp4::RGD:2143	24
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Aqp4::RGD:2143_None_hyperosmotic salinity response::GO:0042538	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	hyperosmotic salinity response::GO:0042538_involved in_AQP1::NCBIGene:358	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l1::MGI:99421_has phenotype_increased liver weight::MP:0002981	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	increased liver weight::MP:0002981_has phenotype_Cav1::MGI:102709	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Cav1::MGI:102709_in 1 to 1 orthology relationship with_Cav1::RGD:2280	96
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Cav1::RGD:2280_None_basal plasma membrane::GO:0009925	52
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	basal plasma membrane::GO:0009925_is part of_AQP1::NCBIGene:358	100
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Aqp4::MGI:107387_in 1 to 1 orthology relationship with_AQP4::NCBIGene:361	12
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	AQP4::NCBIGene:361_involved in_renal water homeostasis::GO:0003091	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	renal water homeostasis::GO:0003091_involved in_AQP1::NCBIGene:358	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l1::MGI:99421_has phenotype_Pallor::HP:0000980	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Pallor::HP:0000980_has phenotype_Fbxw7::MGI:1354695	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Fbxw7::MGI:1354695_in 1 to 1 orthology relationship with_Fbxw7::RGD:2321145	12
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Fbxw7::RGD:2321145_None_cellular response to UV::GO:0034644	12
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	cellular response to UV::GO:0034644_involved in_AQP1::NCBIGene:358	12
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l1::MGI:99421_has phenotype_Hepatic steatosis::HP:0001397	96
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Hepatic steatosis::HP:0001397_has phenotype_CAV1::NCBIGene:857	40
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	CAV1::NCBIGene:857_in 1 to 1 orthology relationship with_Cav1::MGI:102709	140
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Cav1::MGI:102709_None_response to estrogen::GO:0043627	20
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Egfr::RGD:2543_None_cellular response to dexamethasone stimulus::GO:0071549	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	cellular response to dexamethasone stimulus::GO:0071549_involved in_AQP1::NCBIGene:358	32
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Hepatic steatosis::HP:0001397_has phenotype_NFE2L2::NCBIGene:4780	28
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	NFE2L2::NCBIGene:4780_in 1 to 1 orthology relationship with_Nfe2l2::RGD:620360	60
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l2::RGD:620360_None_cellular response to hydrogen peroxide::GO:0070301	44
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	cellular response to hydrogen peroxide::GO:0070301_involved in_AQP1::NCBIGene:358	124
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l1::MGI:99421_has phenotype_decreased hematocrit::MP:0000208	24
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	decreased hematocrit::MP:0000208_has phenotype_Nfe2l2::MGI:108420	24
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l2::MGI:108420_in 1 to 1 orthology relationship with_NFE2L2::NCBIGene:4780	72
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	NFE2L2::NCBIGene:4780_involved in_positive regulation of angiogenesis::GO:0045766	24
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l1::MGI:99421_has phenotype_embryonic growth retardation::MP:0003984	36
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	embryonic growth retardation::MP:0003984_has phenotype_Elavl1::MGI:1100851	8
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Elavl1::MGI:1100851_in 1 to 1 orthology relationship with_elavl1a::ZFIN:ZDB-GENE-990415-245	8
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	elavl1a::ZFIN:ZDB-GENE-990415-245_None_positive regulation of angiogenesis::GO:0045766	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l1::MGI:99421_has phenotype_abnormal blood homeostasis::MP:0009642	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	abnormal blood homeostasis::MP:0009642_has phenotype_Cav1::MGI:102709	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Hepatic steatosis::HP:0001397_has phenotype_Nfe2l2::MGI:108420	24
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Abnormal glucose homeostasis::HP:0011014_has phenotype_Gsk3b::MGI:1861437	12
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Gsk3b::MGI:1861437_in 1 to 1 orthology relationship with_Gsk3b::RGD:70982	32
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Gsk3b::RGD:70982_None_cellular response to hydrogen peroxide::GO:0070301	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l1::MGI:99421_has phenotype_oxidative stress::MP:0003674	48
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	oxidative stress::MP:0003674_has phenotype_Jun::MGI:96646	24
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Jun::MGI:96646_in 1 to 1 orthology relationship with_JUN::NCBIGene:3725	48
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	JUN::NCBIGene:3725_involved in_positive regulation of epithelial cell migration::GO:0010634	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	positive regulation of epithelial cell migration::GO:0010634_involved in_AQP1::NCBIGene:358	32
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Hepatic necrosis::HP:0002605_has phenotype_NFE2L2::NCBIGene:4780	28
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l1::MGI:99421_has phenotype_decreased embryo size::MP:0001698	36
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	decreased embryo size::MP:0001698_has phenotype_Egfr::MGI:95294	24
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Egfr::MGI:95294_in 1 to 1 orthology relationship with_EGFR::NCBIGene:1956	48
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	EGFR::NCBIGene:1956_involved in_wound healing::GO:0042060	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	wound healing::GO:0042060_involved in_AQP1::NCBIGene:358	36
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	oxidative stress::MP:0003674_has phenotype_Nfe2l2::MGI:108420	24
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l1::MGI:99421_has phenotype_Hyperinsulinemia::HP:0000842	80
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Hyperinsulinemia::HP:0000842_has phenotype_Cav1::MGI:102709	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Cav1::RGD:2280_None_cellular response to mechanical stimulus::GO:0071260	52
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Hyperglycemia::HP:0003074_has phenotype_Cav1::MGI:102709	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Hyperinsulinemia::HP:0000842_has phenotype_Stx4a::MGI:893577	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Stx4a::MGI:893577_in 1 to 1 orthology relationship with_Stx4::RGD:621019	8
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Stx4::RGD:621019_None_sarcolemma::GO:0042383	8
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	sarcolemma::GO:0042383_is part of_AQP1::NCBIGene:358	12
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Egfr::MGI:95294	24
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l2::RGD:620360_None_positive regulation of angiogenesis::GO:0045766	44
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Aqp4::RGD:2143_None_carbon dioxide transport::GO:0015670	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	carbon dioxide transport::GO:0015670_involved in_AQP1::NCBIGene:358	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l1::MGI:99421_has phenotype_increased nucleated erythrocyte cell number::MP:0009395	24
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	increased nucleated erythrocyte cell number::MP:0009395_has phenotype_Jun::MGI:96646	24
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Jun::RGD:2943_None_positive regulation of epithelial cell migration::GO:0010634	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Hyperglycemia::HP:0003074_has phenotype_FOS::NCBIGene:2353	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	FOS::NCBIGene:2353_in 1 to 1 orthology relationship with_Fos::MGI:95574	20
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Fos::MGI:95574_involved in_response to drug::GO:0042493	20
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	response to drug::GO:0042493_involved in_AQP1::NCBIGene:358	52
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l1::MGI:99421_has phenotype_Hepatic fibrosis::HP:0001395	72
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Hepatic fibrosis::HP:0001395_has phenotype_NFE2L2::NCBIGene:4780	28
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l1::MGI:99421_has phenotype_Hepatitis::HP:0012115	24
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Hepatitis::HP:0012115_has phenotype_Nfe2l2::MGI:108420	24
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Cav1::MGI:102709_involved in_wound healing::GO:0042060	20
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l1::MGI:99421_has phenotype_decreased circulating glucose level::MP:0005560	28
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	decreased circulating glucose level::MP:0005560_has phenotype_Cav1::MGI:102709	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Aqp8::MGI:1195271	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Aqp8::MGI:1195271_in 1 to 1 orthology relationship with_AQP8::NCBIGene:343	12
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	AQP8::NCBIGene:343_involved in_cellular response to cAMP::GO:0071320	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	cellular response to cAMP::GO:0071320_involved in_AQP1::NCBIGene:358	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	JUN::NCBIGene:3725_involved in_positive regulation of fibroblast proliferation::GO:0048146	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Cav1::MGI:102709_involved in_response to estrogen::GO:0043627	20
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	decreased circulating glucose level::MP:0005560_has phenotype_Gsk3b::MGI:1861437	12
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Gsk3b::MGI:1861437_in 1 to 1 orthology relationship with_GSK3B::NCBIGene:2932	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	GSK3B::NCBIGene:2932_involved in_negative regulation of apoptotic process::GO:0043066	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	negative regulation of apoptotic process::GO:0043066_involved in_AQP1::NCBIGene:358	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l1::MGI:99421_has phenotype_increased circulating alanine transaminase level::MP:0002941	24
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	increased circulating alanine transaminase level::MP:0002941_has phenotype_Nfe2l2::MGI:108420	24
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Hyperinsulinemia::HP:0000842_has phenotype_Aqp7::MGI:1314647	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Aqp7::MGI:1314647_in 1 to 1 orthology relationship with_AQP7::NCBIGene:364	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	AQP7::NCBIGene:364_involved in_glycerol transport::GO:0015793	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	glycerol transport::GO:0015793_involved in_AQP1::NCBIGene:358	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	NFE2L2::NCBIGene:4780_involved in_cellular response to hydrogen peroxide::GO:0070301	24
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l1::MGI:99421_has phenotype_Insulin resistance::HP:0000855	92
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Insulin resistance::HP:0000855_has phenotype_NFE2L2::NCBIGene:4780	28
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Hyperinsulinemia::HP:0000842_has phenotype_CAV1::NCBIGene:857	40
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Cav1::MGI:102709_is part of_basal plasma membrane::GO:0009925	20
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	EGFR::NCBIGene:1956_involved in_cellular response to dexamethasone stimulus::GO:0071549	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	JUN::NCBIGene:3725_involved in_response to drug::GO:0042493	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	embryonic growth retardation::MP:0003984_has phenotype_Jun::MGI:96646	24
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l2::MGI:108420_involved in_cellular response to hydrogen peroxide::GO:0070301	20
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Insulin resistance::HP:0000855_has phenotype_CAV1::NCBIGene:857	40
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l2::MGI:108420_None_positive regulation of angiogenesis::GO:0045766	20
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Insulin resistance::HP:0000855_has phenotype_Cav1::MGI:102709	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Hepatic fibrosis::HP:0001395_has phenotype_CAV1::NCBIGene:857	40
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Cav1::MGI:102709_involved in_cellular response to mechanical stimulus::GO:0071260	20
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	decreased embryo size::MP:0001698_has phenotype_Fbxw7::MGI:1354695	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Cav1::MGI:102709_None_cellular response to mechanical stimulus::GO:0071260	20
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Cav1::MGI:102709	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l2::MGI:108420_None_cellular response to hydrogen peroxide::GO:0070301	20
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l1::MGI:99421_has phenotype_abnormal pancreatic beta cell morphology::MP:0005217	24
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	abnormal pancreatic beta cell morphology::MP:0005217_has phenotype_Egfr::MGI:95294	24
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Cav1::MGI:102709_None_basal plasma membrane::GO:0009925	20
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	EGFR::NCBIGene:1956_is part of_nuclear membrane::GO:0031965	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	nuclear membrane::GO:0031965_is part of_AQP1::NCBIGene:358	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	AQP4::NCBIGene:361_involved in_multicellular organismal water homeostasis::GO:0050891	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	multicellular organismal water homeostasis::GO:0050891_involved in_AQP1::NCBIGene:358	8
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	AQP4::NCBIGene:361_involved in_Bile secretion::KEGG-path:maphsa04976	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Bile secretion::KEGG-path:maphsa04976_involved in_AQP1::NCBIGene:358	8
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Aqp4::RGD:2143_None_basal plasma membrane::GO:0009925	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Aqp4::RGD:2143_None_renal water absorption::GO:0070295	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	renal water absorption::GO:0070295_involved in_AQP1::NCBIGene:358	8
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Gsk3b::MGI:1861437	12
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Gsk3b::RGD:70982_None_cellular response to mechanical stimulus::GO:0071260	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	decreased embryo size::MP:0001698_has phenotype_Exoc4::MGI:1096376	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Exoc4::MGI:1096376_in 1 to 1 orthology relationship with_Sec8::FlyBase:FBgn0266672	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Sec8::FlyBase:FBgn0266672_None_basal plasma membrane::GO:0009925	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Jun::MGI:96646_in 1 to 1 orthology relationship with_jun::ZFIN:ZDB-GENE-030131-7859	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	jun::ZFIN:ZDB-GENE-030131-7859_involved in_response to drug::GO:0042493	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Egfr::RGD:2543_None_positive regulation of fibroblast proliferation::GO:0048146	16
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	NFE2L2::NCBIGene:4780_involved in_cellular response to hypoxia::GO:0071456	24
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l1::MGI:99421_has phenotype_Hypoinsulinemia::HP:0040216	12
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Hypoinsulinemia::HP:0040216_has phenotype_Gsk3b::MGI:1861437	12
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	AQP8::NCBIGene:343_involved in_Bile secretion::KEGG-path:maphsa04976	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Nfe2l1::MGI:99421_has phenotype_increased circulating aspartate transaminase level::MP:0005343	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	increased circulating aspartate transaminase level::MP:0005343_has phenotype_Aqp11::MGI:1913583	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Aqp11::MGI:1913583_in 1 to 1 orthology relationship with_Aqp11::RGD:628763	8
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Aqp11::RGD:628763_None_glycerol transport::GO:0015793	8
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Insulin resistance::HP:0000855_has phenotype_FOS::NCBIGene:2353	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Aqp7::MGI:1314647_in 1 to 1 orthology relationship with_Aqp7::RGD:2145	12
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Aqp7::RGD:2145_None_glycerol transport::GO:0015793	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Aqp4::RGD:2143_None_sarcolemma::GO:0042383	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Aqp11::MGI:1913583	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Hyperinsulinemia::HP:0000842_has phenotype_FOS::NCBIGene:2353	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Aqp7::RGD:2145_None_brush border membrane::GO:0031526	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	brush border membrane::GO:0031526_is part of_AQP1::NCBIGene:358	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Aqp7::RGD:2145_None_renal water absorption::GO:0070295	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Insulin resistance::HP:0000855_has phenotype_Stx4a::MGI:893577	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Aqp4::RGD:2143_None_multicellular organismal water homeostasis::GO:0050891	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Hepatic fibrosis::HP:0001395_has phenotype_FOS::NCBIGene:2353	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	AQP8::NCBIGene:343_is part of_apical part of cell::GO:0045177	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	apical part of cell::GO:0045177_is part of_AQP1::NCBIGene:358	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Aqp8::MGI:1195271_in 1 to 1 orthology relationship with_Aqp8::RGD:2146	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Aqp8::RGD:2146_None_cellular response to cAMP::GO:0071320	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	embryonic growth retardation::MP:0003984_has phenotype_Fbxw7::MGI:1354695	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	elavl1a::ZFIN:ZDB-GENE-990415-245_involved in_positive regulation of angiogenesis::GO:0045766	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Hepatic steatosis::HP:0001397_has phenotype_FOS::NCBIGene:2353	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	decreased embryo size::MP:0001698_has phenotype_Hcfc1::MGI:105942	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	Hcfc1::MGI:105942_in 1 to 1 orthology relationship with_HCFC1::NCBIGene:3054	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	HCFC1::NCBIGene:3054_is part of_axon::GO:0030424	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	axon::GO:0030424_is part of_AQP1::NCBIGene:358	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	homeostasis/metabolism phenotype::MP:0005376_has phenotype_App::MGI:88059	4
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	App::MGI:88059_in 1 to 1 orthology relationship with_App::RGD:2139	8
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	App::RGD:2139_None_cellular response to cAMP::GO:0071320	8
NFE2L1::NCBIGene:4779	AQP1::NCBIGene:358	992	growth/size/body region phenotype::MP:0005378_has phenotype_App::MGI:88059	4
NFE2L1::NCBIGene:4779	Aqp1::NCBIGene:11826	0	NA	0
NFE2L1::NCBIGene:4779	ENGASE::NCBIGene:64772	16	NFE2L1::NCBIGene:4779_in 1 to 1 orthology relationship with_Nfe2l1::MGI:99421	16
NFE2L1::NCBIGene:4779	ENGASE::NCBIGene:64772	16	Nfe2l1::MGI:99421_has phenotype_Hepatic fibrosis::HP:0001395	4
NFE2L1::NCBIGene:4779	ENGASE::NCBIGene:64772	16	Hepatic fibrosis::HP:0001395_has phenotype_Amfr::MGI:1345634	4
NFE2L1::NCBIGene:4779	ENGASE::NCBIGene:64772	16	Amfr::MGI:1345634_in 1 to 1 orthology relationship with_AMFR::NCBIGene:267	12
NFE2L1::NCBIGene:4779	ENGASE::NCBIGene:64772	16	AMFR::NCBIGene:267_involved in_protein folding::GO:0006457	12
NFE2L1::NCBIGene:4779	ENGASE::NCBIGene:64772	16	protein folding::GO:0006457_involved in_ENGASE::NCBIGene:64772	16
NFE2L1::NCBIGene:4779	ENGASE::NCBIGene:64772	16	Nfe2l1::MGI:99421_has phenotype_Hepatic steatosis::HP:0001397	4
NFE2L1::NCBIGene:4779	ENGASE::NCBIGene:64772	16	Hepatic steatosis::HP:0001397_has phenotype_Amfr::MGI:1345634	4
NFE2L1::NCBIGene:4779	ENGASE::NCBIGene:64772	16	Nfe2l1::MGI:99421_has phenotype_embryonic growth retardation::MP:0003984	4
NFE2L1::NCBIGene:4779	ENGASE::NCBIGene:64772	16	embryonic growth retardation::MP:0003984_has phenotype_Derl1::MGI:1915069	4
NFE2L1::NCBIGene:4779	ENGASE::NCBIGene:64772	16	Derl1::MGI:1915069_in 1 to 1 orthology relationship with_DERL1::NCBIGene:79139	4
NFE2L1::NCBIGene:4779	ENGASE::NCBIGene:64772	16	DERL1::NCBIGene:79139_involved in_protein folding::GO:0006457	4
NFE2L1::NCBIGene:4779	ENGASE::NCBIGene:64772	16	Nfe2l1::MGI:99421_has phenotype_Hepatitis::HP:0012115	4
NFE2L1::NCBIGene:4779	ENGASE::NCBIGene:64772	16	Hepatitis::HP:0012115_has phenotype_Amfr::MGI:1345634	4
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	NFE2L1::NCBIGene:4779_in 1 to 1 orthology relationship with_Nfe2l1::MGI:99421	280
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Nfe2l1::MGI:99421_has phenotype_abnormal blood homeostasis::MP:0009642	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	abnormal blood homeostasis::MP:0009642_has phenotype_Cav1::MGI:102709	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Cav1::MGI:102709_in 1 to 1 orthology relationship with_CAV1::NCBIGene:857	32
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	CAV1::NCBIGene:857_involved in_response to calcium ion::GO:0051592	32
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	response to calcium ion::GO:0051592_involved in_AQP3::NCBIGene:360	156
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Nfe2l1::MGI:99421_has phenotype_increased liver weight::MP:0002981	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	increased liver weight::MP:0002981_has phenotype_Cav1::MGI:102709	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Nfe2l1::MGI:99421_has phenotype_Hyperinsulinemia::HP:0000842	52
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Hyperinsulinemia::HP:0000842_has phenotype_Aqp7::MGI:1314647	32
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Aqp7::MGI:1314647_in 1 to 1 orthology relationship with_AQP7::NCBIGene:364	16
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	AQP7::NCBIGene:364_enables_glycerol channel activity::GO:0015254	4
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	glycerol channel activity::GO:0015254_enables_AQP3::NCBIGene:360	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Cav1::MGI:102709_in 1 to 1 orthology relationship with_Cav1::RGD:2280	32
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Cav1::RGD:2280_None_response to calcium ion::GO:0051592	52
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Nfe2l1::MGI:99421_has phenotype_Hepatocellular carcinoma::HP:0001402	4
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Hepatocellular carcinoma::HP:0001402_has phenotype_NFE2L2::NCBIGene:4780	4
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	NFE2L2::NCBIGene:4780_in 1 to 1 orthology relationship with_Nfe2l2::RGD:620360	20
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Nfe2l2::RGD:620360_None_cellular response to hypoxia::GO:0071456	44
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	cellular response to hypoxia::GO:0071456_involved in_AQP3::NCBIGene:360	68
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Nfe2l1::MGI:99421_has phenotype_homeostasis/metabolism phenotype::MP:0005376	40
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Nfe2l2::MGI:108420	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Nfe2l2::MGI:108420_in 1 to 1 orthology relationship with_NFE2L2::NCBIGene:4780	24
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	NFE2L2::NCBIGene:4780_involved in_cellular response to hypoxia::GO:0071456	24
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	AQP7::NCBIGene:364_involved in_excretion::GO:0007588	4
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	excretion::GO:0007588_involved in_AQP3::NCBIGene:360	4
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Nfe2l1::MGI:99421_has phenotype_Insulin resistance::HP:0000855	24
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Insulin resistance::HP:0000855_has phenotype_CAV1::NCBIGene:857	12
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	CAV1::NCBIGene:857_in 1 to 1 orthology relationship with_Cav1::MGI:102709	40
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Cav1::MGI:102709_involved in_response to calcium ion::GO:0051592	20
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Nfe2l1::MGI:99421_has phenotype_oxidative stress::MP:0003674	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	oxidative stress::MP:0003674_has phenotype_Nfe2l2::MGI:108420	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Nfe2l2::MGI:108420_in 1 to 1 orthology relationship with_Nfe2l2::RGD:620360	24
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Nfe2l1::MGI:99421_has phenotype_Hepatic fibrosis::HP:0001395	16
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Hepatic fibrosis::HP:0001395_has phenotype_NFE2L2::NCBIGene:4780	4
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Hyperinsulinemia::HP:0000842_has phenotype_Cav1::MGI:102709	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Nfe2l1::MGI:99421_has phenotype_abnormal pancreatic beta cell morphology::MP:0005217	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	abnormal pancreatic beta cell morphology::MP:0005217_has phenotype_Egfr::MGI:95294	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Egfr::MGI:95294_in 1 to 1 orthology relationship with_EGFR::NCBIGene:1956	16
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	EGFR::NCBIGene:1956_involved in_response to calcium ion::GO:0051592	16
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Aqp7::MGI:1314647_in 1 to 1 orthology relationship with_Aqp7::RGD:2145	16
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Aqp7::RGD:2145_None_urea transport::GO:0015840	4
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	urea transport::GO:0015840_involved in_AQP3::NCBIGene:360	12
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Nfe2l1::MGI:99421_has phenotype_Abnormal glucose homeostasis::HP:0011014	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Abnormal glucose homeostasis::HP:0011014_has phenotype_Cav1::MGI:102709	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	CAV1::NCBIGene:857_in 1 to 1 orthology relationship with_Cav1::RGD:2280	20
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Nfe2l1::MGI:99421_has phenotype_Hepatic steatosis::HP:0001397	24
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Hepatic steatosis::HP:0001397_has phenotype_CAV1::NCBIGene:857	12
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Nfe2l1::MGI:99421_has phenotype_increased circulating alanine transaminase level::MP:0002941	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	increased circulating alanine transaminase level::MP:0002941_has phenotype_Nfe2l2::MGI:108420	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Nfe2l1::MGI:99421_has phenotype_Hyperglycemia::HP:0003074	20
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Hyperglycemia::HP:0003074_has phenotype_CAV1::NCBIGene:857	12
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Hepatic fibrosis::HP:0001395_has phenotype_CAV1::NCBIGene:857	12
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Cav1::MGI:102709	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Nfe2l1::MGI:99421_has phenotype_decreased circulating glucose level::MP:0005560	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	decreased circulating glucose level::MP:0005560_has phenotype_Cav1::MGI:102709	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Aqp7::RGD:2145_None_renal water absorption::GO:0070295	4
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	renal water absorption::GO:0070295_involved in_AQP3::NCBIGene:360	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Aqp11::MGI:1913583	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Aqp11::MGI:1913583_in 1 to 1 orthology relationship with_Aqp11::RGD:628763	16
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Aqp11::RGD:628763_None_urea transport::GO:0015840	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Insulin resistance::HP:0000855_has phenotype_Cav1::MGI:102709	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Aqp7::RGD:2145_None_glycerol channel activity::GO:0015254	4
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Hyperinsulinemia::HP:0000842_has phenotype_CAV1::NCBIGene:857	12
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Nfe2l1::MGI:99421_has phenotype_increased circulating aspartate transaminase level::MP:0005343	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	increased circulating aspartate transaminase level::MP:0005343_has phenotype_Aqp11::MGI:1913583	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Aqp11::RGD:628763_None_glycerol transport::GO:0015793	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	glycerol transport::GO:0015793_involved in_AQP3::NCBIGene:360	16
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Cav1::MGI:102709_None_response to calcium ion::GO:0051592	20
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Hyperglycemia::HP:0003074_has phenotype_Cav1::MGI:102709	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Nfe2l1::MGI:99421_has phenotype_decreased hematocrit::MP:0000208	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	decreased hematocrit::MP:0000208_has phenotype_Nfe2l2::MGI:108420	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Nfe2l1::MGI:99421_has phenotype_growth/size/body region phenotype::MP:0005378	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	growth/size/body region phenotype::MP:0005378_has phenotype_Egfr::MGI:95294	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Hepatic steatosis::HP:0001397_has phenotype_Nfe2l2::MGI:108420	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Egfr::MGI:95294	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Hepatic steatosis::HP:0001397_has phenotype_NFE2L2::NCBIGene:4780	4
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Nfe2l1::MGI:99421_has phenotype_decreased embryo size::MP:0001698	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	decreased embryo size::MP:0001698_has phenotype_Egfr::MGI:95294	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Egfr::MGI:95294_in 1 to 1 orthology relationship with_Egfr::RGD:2543	16
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Egfr::RGD:2543_None_response to calcium ion::GO:0051592	16
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Nfe2l1::MGI:99421_has phenotype_Hepatitis::HP:0012115	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Hepatitis::HP:0012115_has phenotype_Nfe2l2::MGI:108420	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	AQP7::NCBIGene:364_is part of_cell-cell junction::GO:0005911	4
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	cell-cell junction::GO:0005911_is part of_AQP3::NCBIGene:360	4
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Aqp4::MGI:107387	8
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Aqp4::MGI:107387_in 1 to 1 orthology relationship with_Aqp4::RGD:2143	4
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Aqp4::RGD:2143_None_renal water absorption::GO:0070295	4
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Aqp7::RGD:2145_None_glycerol transport::GO:0015793	4
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Insulin resistance::HP:0000855_has phenotype_NFE2L2::NCBIGene:4780	4
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Nfe2l1::MGI:99421_has phenotype_Hepatic necrosis::HP:0002605	4
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Hepatic necrosis::HP:0002605_has phenotype_NFE2L2::NCBIGene:4780	4
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	AQP7::NCBIGene:364_involved in_glycerol transport::GO:0015793	4
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	Aqp4::MGI:107387_in 1 to 1 orthology relationship with_AQP4::NCBIGene:361	4
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	AQP4::NCBIGene:361_involved in_renal water homeostasis::GO:0003091	4
NFE2L1::NCBIGene:4779	AQP3::NCBIGene:360	280	renal water homeostasis::GO:0003091_involved in_AQP3::NCBIGene:360	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	NFE2L1::NCBIGene:4779_in 1 to 1 orthology relationship with_Nfe2l1::MGI:99421	132
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Nfe2l1::MGI:99421_has phenotype_Insulin resistance::HP:0000855	16
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Insulin resistance::HP:0000855_has phenotype_CAV1::NCBIGene:857	8
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	CAV1::NCBIGene:857_in 1 to 1 orthology relationship with_Cav1::MGI:102709	40
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Cav1::MGI:102709_is part of_cell surface::GO:0009986	20
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	cell surface::GO:0009986_is part of_AQP11::NCBIGene:282679	44
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Nfe2l1::MGI:99421_has phenotype_abnormal blood homeostasis::MP:0009642	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	abnormal blood homeostasis::MP:0009642_has phenotype_Cav1::MGI:102709	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Cav1::MGI:102709_in 1 to 1 orthology relationship with_CAV1::NCBIGene:857	32
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	CAV1::NCBIGene:857_involved in_protein homooligomerization::GO:0051260	32
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	protein homooligomerization::GO:0051260_involved in_AQP11::NCBIGene:282679	56
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Nfe2l1::MGI:99421_has phenotype_Hyperglycemia::HP:0003074	12
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Hyperglycemia::HP:0003074_has phenotype_CAV1::NCBIGene:857	8
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Cav1::MGI:102709_involved in_protein homooligomerization::GO:0051260	20
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Nfe2l1::MGI:99421_has phenotype_decreased circulating glucose level::MP:0005560	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	decreased circulating glucose level::MP:0005560_has phenotype_Cav1::MGI:102709	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Nfe2l1::MGI:99421_has phenotype_decreased embryo size::MP:0001698	8
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	decreased embryo size::MP:0001698_has phenotype_Hcfc1::MGI:105942	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Hcfc1::MGI:105942_in 1 to 1 orthology relationship with_HCFC1::NCBIGene:3054	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	HCFC1::NCBIGene:3054_is part of_dendrite::GO:0030425	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	dendrite::GO:0030425_is part of_AQP11::NCBIGene:282679	16
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Nfe2l1::MGI:99421_has phenotype_Hyperinsulinemia::HP:0000842	16
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Hyperinsulinemia::HP:0000842_has phenotype_Cav1::MGI:102709	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Nfe2l1::MGI:99421_has phenotype_Abnormal glucose homeostasis::HP:0011014	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Abnormal glucose homeostasis::HP:0011014_has phenotype_Cav1::MGI:102709	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Hyperinsulinemia::HP:0000842_has phenotype_Stx4a::MGI:893577	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Stx4a::MGI:893577_in 1 to 1 orthology relationship with_STX4::NCBIGene:6810	8
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	STX4::NCBIGene:6810_is part of_cell surface::GO:0009986	8
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Nfe2l1::MGI:99421_has phenotype_homeostasis/metabolism phenotype::MP:0005376	16
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Egfr::MGI:95294	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Egfr::MGI:95294_in 1 to 1 orthology relationship with_EGFR::NCBIGene:1956	16
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	EGFR::NCBIGene:1956_is part of_cell surface::GO:0009986	16
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Nfe2l1::MGI:99421_has phenotype_Hepatic steatosis::HP:0001397	12
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Hepatic steatosis::HP:0001397_has phenotype_CAV1::NCBIGene:857	8
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Hepatic steatosis::HP:0001397_has phenotype_Amfr::MGI:1345634	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Amfr::MGI:1345634_in 1 to 1 orthology relationship with_AMFR::NCBIGene:267	12
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	AMFR::NCBIGene:267_is part of_dendrite::GO:0030425	12
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Nfe2l1::MGI:99421_has phenotype_increased liver weight::MP:0002981	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	increased liver weight::MP:0002981_has phenotype_Cav1::MGI:102709	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	decreased embryo size::MP:0001698_has phenotype_Egfr::MGI:95294	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Insulin resistance::HP:0000855_has phenotype_Stx4a::MGI:893577	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Aqp11::MGI:1913583	8
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Aqp11::MGI:1913583_in 1 to 1 orthology relationship with_Aqp11::RGD:628763	16
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Aqp11::RGD:628763_None_proximal tubule development::GO:0072014	8
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	proximal tubule development::GO:0072014_involved in_AQP11::NCBIGene:282679	8
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Hyperinsulinemia::HP:0000842_has phenotype_CAV1::NCBIGene:857	8
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Nfe2l1::MGI:99421_has phenotype_increased circulating aspartate transaminase level::MP:0005343	8
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	increased circulating aspartate transaminase level::MP:0005343_has phenotype_Aqp11::MGI:1913583	8
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Nfe2l1::MGI:99421_has phenotype_Hepatic fibrosis::HP:0001395	12
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Hepatic fibrosis::HP:0001395_has phenotype_CAV1::NCBIGene:857	8
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Aqp11::RGD:628763_None_endosomal lumen acidification::GO:0048388	8
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	endosomal lumen acidification::GO:0048388_involved in_AQP11::NCBIGene:282679	8
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Nfe2l1::MGI:99421_has phenotype_abnormal pancreatic beta cell morphology::MP:0005217	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	abnormal pancreatic beta cell morphology::MP:0005217_has phenotype_Egfr::MGI:95294	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Nfe2l1::MGI:99421_has phenotype_Hepatitis::HP:0012115	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Hepatitis::HP:0012115_has phenotype_Amfr::MGI:1345634	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Nfe2l1::MGI:99421_has phenotype_embryonic growth retardation::MP:0003984	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	embryonic growth retardation::MP:0003984_has phenotype_Derl1::MGI:1915069	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Derl1::MGI:1915069_in 1 to 1 orthology relationship with_DERL1::NCBIGene:79139	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	DERL1::NCBIGene:79139_involved in_protein homooligomerization::GO:0051260	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Hyperglycemia::HP:0003074_has phenotype_Cav1::MGI:102709	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Nfe2l1::MGI:99421_has phenotype_growth/size/body region phenotype::MP:0005378	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	growth/size/body region phenotype::MP:0005378_has phenotype_Egfr::MGI:95294	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Insulin resistance::HP:0000855_has phenotype_Cav1::MGI:102709	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Cav1::MGI:102709	4
NFE2L1::NCBIGene:4779	AQP11::NCBIGene:282679	132	Hepatic fibrosis::HP:0001395_has phenotype_Amfr::MGI:1345634	4
ENGASE::NCBIGene:64772	NGLY1::NCBIGene:55768	0	NA	0
ENGASE::NCBIGene:64772	AQP1::NCBIGene:358	0	NA	0
ENGASE::NCBIGene:64772	Aqp1::NCBIGene:11826	0	NA	0
ENGASE::NCBIGene:64772	NFE2L1::NCBIGene:4779	0	NA	0
ENGASE::NCBIGene:64772	AQP3::NCBIGene:360	0	NA	0
ENGASE::NCBIGene:64772	AQP11::NCBIGene:282679	0	NA	0
AQP3::NCBIGene:360	NGLY1::NCBIGene:55768	0	NA	0
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	AQP3::NCBIGene:360_in 1 to 1 orthology relationship with_Aqp3::MGI:1333777	2864
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp3::MGI:1333777_has phenotype_decreased urine osmolality::MP:0002988	360
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	decreased urine osmolality::MP:0002988_has phenotype_Avp::MGI:88121	28
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Avp::MGI:88121_in 1 to 1 orthology relationship with_AVP::NCBIGene:551	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	AVP::NCBIGene:551_involved in_renal water homeostasis::GO:0003091	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	renal water homeostasis::GO:0003091_involved in_AQP1::NCBIGene:358	40
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp3::MGI:1333777_has phenotype_decreased bone mineral content::MP:0010124	252
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	decreased bone mineral content::MP:0010124_has phenotype_Aqp1::MGI:103201	252
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::MGI:103201_in 1 to 1 orthology relationship with_Aqp1::RGD:2141	1824
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_glomerular filtration::GO:0003094	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	glomerular filtration::GO:0003094_involved in_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp3::MGI:1333777_has phenotype_hearing/vestibular/ear phenotype::MP:0005377	292
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	hearing/vestibular/ear phenotype::MP:0005377_has phenotype_Aqp1::MGI:103201	252
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_positive regulation of epithelial cell migration::GO:0010634	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	positive regulation of epithelial cell migration::GO:0010634_involved in_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp3::MGI:1333777_has phenotype_Elevated tissue non-specific alkaline phosphatase::HP:0010679	252
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Elevated tissue non-specific alkaline phosphatase::HP:0010679_has phenotype_Aqp1::MGI:103201	252
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_lateral ventricle development::GO:0021670	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	lateral ventricle development::GO:0021670_involved in_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_establishment or maintenance of actin cytoskeleton polarity::GO:0030950	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	establishment or maintenance of actin cytoskeleton polarity::GO:0030950_involved in_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	decreased urine osmolality::MP:0002988_has phenotype_Aqp2::MGI:1096865	40
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp2::MGI:1096865_in 1 to 1 orthology relationship with_AQP2::NCBIGene:359	100
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	AQP2::NCBIGene:359_involved in_cellular response to mercury ion::GO:0071288	20
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	cellular response to mercury ion::GO:0071288_involved in_AQP1::NCBIGene:358	96
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	AQP2::NCBIGene:359_involved in_renal water homeostasis::GO:0003091	20
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_cellular response to UV::GO:0034644	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	cellular response to UV::GO:0034644_involved in_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_lipid digestion::GO:0044241	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	lipid digestion::GO:0044241_involved in_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::MGI:103201_in 1 to 1 orthology relationship with_aqp1a.1::ZFIN:ZDB-GENE-030131-7764	192
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	aqp1a.1::ZFIN:ZDB-GENE-030131-7764_None_carbon dioxide transport::GO:0015670	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	carbon dioxide transport::GO:0015670_involved in_AQP1::NCBIGene:358	124
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp3::MGI:1333777_has phenotype_vision/eye phenotype::MP:0005391	328
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	vision/eye phenotype::MP:0005391_has phenotype_Aqp5::MGI:106215	40
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp5::MGI:106215_in 1 to 1 orthology relationship with_AQP5::NCBIGene:362	40
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	AQP5::NCBIGene:362_involved in_camera-type eye morphogenesis::GO:0048593	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	camera-type eye morphogenesis::GO:0048593_involved in_AQP1::NCBIGene:358	48
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp3::MGI:1333777_has phenotype_Increased blood urea nitrogen::HP:0003138	88
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Increased blood urea nitrogen::HP:0003138_has phenotype_Aqp2::MGI:1096865	40
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	AQP2::NCBIGene:359_involved in_glycerol transport::GO:0015793	20
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	glycerol transport::GO:0015793_involved in_AQP1::NCBIGene:358	112
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp3::MGI:1333777_has phenotype_abnormal renal water transport::MP:0011443	288
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	abnormal renal water transport::MP:0011443_has phenotype_Aqp1::MGI:103201	252
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_cellular response to retinoic acid::GO:0071300	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	cellular response to retinoic acid::GO:0071300_involved in_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	decreased urine osmolality::MP:0002988_has phenotype_Aqp1::MGI:103201	252
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_pancreatic juice secretion::GO:0030157	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	pancreatic juice secretion::GO:0030157_involved in_AQP1::NCBIGene:358	48
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp3::MGI:1333777_has phenotype_Osteopenia::HP:0000938	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Osteopenia::HP:0000938_has phenotype_AVP::NCBIGene:551	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	AVP::NCBIGene:551_in 1 to 1 orthology relationship with_Avp::RGD:2184	24
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Avp::RGD:2184_None_hyperosmotic salinity response::GO:0042538	16
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	hyperosmotic salinity response::GO:0042538_involved in_AQP1::NCBIGene:358	68
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_positive regulation of lamellipodium assembly::GO:0010592	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	positive regulation of lamellipodium assembly::GO:0010592_involved in_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp3::MGI:1333777_has phenotype_increased sensitivity to induced morbidity/mortality::MP:0009763	44
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	increased sensitivity to induced morbidity/mortality::MP:0009763_has phenotype_Egfr::MGI:95294	24
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Egfr::MGI:95294_in 1 to 1 orthology relationship with_Egfr::RGD:2543	36
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Egfr::RGD:2543_None_cellular response to dexamethasone stimulus::GO:0071549	12
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	cellular response to dexamethasone stimulus::GO:0071549_involved in_AQP1::NCBIGene:358	56
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_odontogenesis::GO:0042476	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	odontogenesis::GO:0042476_involved in_AQP1::NCBIGene:358	48
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp3::MGI:1333777_has phenotype_increased blood osmolality::MP:0008997	292
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	increased blood osmolality::MP:0008997_has phenotype_Aqp1::MGI:103201	252
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	aqp1a.1::ZFIN:ZDB-GENE-030131-7764_involved in_ammonium transport::GO:0015696	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	ammonium transport::GO:0015696_involved in_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp3::MGI:1333777_has phenotype_Elevated serum creatinine::HP:0003259	56
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Elevated serum creatinine::HP:0003259_has phenotype_Egfr::MGI:95294	24
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Egfr::MGI:95294_in 1 to 1 orthology relationship with_EGFR::NCBIGene:1956	36
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	EGFR::NCBIGene:1956_involved in_wound healing::GO:0042060	12
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	wound healing::GO:0042060_involved in_AQP1::NCBIGene:358	12
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	AQP5::NCBIGene:362_involved in_pancreatic juice secretion::GO:0030157	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp3::MGI:1333777_has phenotype_Polydipsia::HP:0001959	132
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Polydipsia::HP:0001959_has phenotype_AVP::NCBIGene:551	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	AVP::NCBIGene:551_in 1 to 1 orthology relationship with_Avp::MGI:88121	40
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Avp::MGI:88121_None_negative regulation of cysteine-type endopeptidase activity involved in apoptotic process::GO:0043154	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	negative regulation of cysteine-type endopeptidase activity involved in apoptotic process::GO:0043154_involved in_AQP1::NCBIGene:358	72
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	increased blood osmolality::MP:0008997_has phenotype_Aqp2::MGI:1096865	40
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp2::MGI:1096865_in 1 to 1 orthology relationship with_Aqp2::RGD:2142	100
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp2::RGD:2142_None_renal water transport::GO:0003097	28
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	renal water transport::GO:0003097_involved in_AQP1::NCBIGene:358	96
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_response to estrogen::GO:0043627	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	response to estrogen::GO:0043627_involved in_AQP1::NCBIGene:358	48
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_ephrin receptor binding::GO:0046875	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	ephrin receptor binding::GO:0046875_enables_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp3::MGI:1333777_has phenotype_Hyperproteinemia::HP:0002152	252
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Hyperproteinemia::HP:0002152_has phenotype_Aqp1::MGI:103201	252
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	aqp1a.1::ZFIN:ZDB-GENE-030131-7764_enables_ammonium transmembrane transporter activity::GO:0008519	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	ammonium transmembrane transporter activity::GO:0008519_enables_AQP1::NCBIGene:358	64
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_cellular response to hydrogen peroxide::GO:0070301	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	cellular response to hydrogen peroxide::GO:0070301_involved in_AQP1::NCBIGene:358	64
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	vision/eye phenotype::MP:0005391_has phenotype_Aqp1::MGI:103201	252
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_axon terminus::GO:0043679	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	axon terminus::GO:0043679_is part of_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Avp::MGI:88121_in 1 to 1 orthology relationship with_Avp::RGD:2184	24
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Avp::RGD:2184_None_multicellular organismal water homeostasis::GO:0050891	16
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	multicellular organismal water homeostasis::GO:0050891_involved in_AQP1::NCBIGene:358	88
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_maintenance of symbiont-containing vacuole by host::GO:0085018	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	maintenance of symbiont-containing vacuole by host::GO:0085018_involved in_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Increased blood urea nitrogen::HP:0003138_has phenotype_Cav1::MGI:102709	16
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Cav1::MGI:102709_in 1 to 1 orthology relationship with_CAV1::NCBIGene:857	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	CAV1::NCBIGene:857_involved in_response to estrogen::GO:0043627	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	decreased urine osmolality::MP:0002988_has phenotype_Aqp4::MGI:107387	36
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp4::MGI:107387_in 1 to 1 orthology relationship with_Aqp4::RGD:2143	72
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp4::RGD:2143_None_basal plasma membrane::GO:0009925	12
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	basal plasma membrane::GO:0009925_is part of_AQP1::NCBIGene:358	68
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	aqp1a.1::ZFIN:ZDB-GENE-030131-7764_enables_carbon dioxide transmembrane transporter activity::GO:0035379	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	carbon dioxide transmembrane transporter activity::GO:0035379_enables_AQP1::NCBIGene:358	96
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp3::MGI:1333777_has phenotype_Polyuria::HP:0000103	128
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Polyuria::HP:0000103_has phenotype_Aqp2::MGI:1096865	40
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_corticotropin secretion::GO:0051458	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	corticotropin secretion::GO:0051458_involved in_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_positive regulation of saliva secretion::GO:0046878	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	positive regulation of saliva secretion::GO:0046878_involved in_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_ammonium transmembrane transporter activity::GO:0008519	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_carbon dioxide transport::GO:0015670	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_positive regulation of angiogenesis::GO:0045766	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	positive regulation of angiogenesis::GO:0045766_involved in_AQP1::NCBIGene:358	72
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_cerebrospinal fluid secretion::GO:0033326	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	cerebrospinal fluid secretion::GO:0033326_involved in_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp3::MGI:1333777_has phenotype_increased susceptibility to induced colitis::MP:0008537	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	increased susceptibility to induced colitis::MP:0008537_has phenotype_Nfe2l2::MGI:108420	24
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Nfe2l2::MGI:108420_in 1 to 1 orthology relationship with_Nfe2l2::RGD:620360	12
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Nfe2l2::RGD:620360_None_positive regulation of angiogenesis::GO:0045766	12
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_cellular response to nitric oxide::GO:0071732	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	cellular response to nitric oxide::GO:0071732_involved in_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	vision/eye phenotype::MP:0005391_has phenotype_Aqp4::MGI:107387	36
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp4::MGI:107387_in 1 to 1 orthology relationship with_AQP4::NCBIGene:361	36
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	AQP4::NCBIGene:361_involved in_Bile secretion::KEGG-path:maphsa04976	12
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Bile secretion::KEGG-path:maphsa04976_involved in_AQP1::NCBIGene:358	12
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp2::RGD:2142_None_cell volume homeostasis::GO:0006884	28
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	cell volume homeostasis::GO:0006884_involved in_AQP1::NCBIGene:358	76
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_hyperosmotic salinity response::GO:0042538	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_sarcolemma::GO:0042383	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	sarcolemma::GO:0042383_is part of_AQP1::NCBIGene:358	44
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_cellular response to mechanical stimulus::GO:0071260	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	cellular response to mechanical stimulus::GO:0071260_involved in_AQP1::NCBIGene:358	52
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_intracellular cGMP activated cation channel activity::GO:0005223	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	intracellular cGMP activated cation channel activity::GO:0005223_enables_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_cellular response to hypoxia::GO:0071456	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	cellular response to hypoxia::GO:0071456_involved in_AQP1::NCBIGene:358	48
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_brush border membrane::GO:0031526	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	brush border membrane::GO:0031526_is part of_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_metanephric proximal straight tubule development::GO:0072230	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	metanephric proximal straight tubule development::GO:0072230_involved in_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_cellular hyperosmotic response::GO:0071474	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	cellular hyperosmotic response::GO:0071474_involved in_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_symbiont-containing vacuole membrane::GO:0020005	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	symbiont-containing vacuole membrane::GO:0020005_is part of_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Polyuria::HP:0000103_has phenotype_AQP2::NCBIGene:359	60
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	AQP2::NCBIGene:359_in 1 to 1 orthology relationship with_Aqp2::MGI:1096865	80
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp2::MGI:1096865_involved in_glycerol transport::GO:0015793	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_multicellular organismal water homeostasis::GO:0050891	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_brush border::GO:0005903	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	brush border::GO:0005903_is part of_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_metanephric descending thin limb development::GO:0072220	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	metanephric descending thin limb development::GO:0072220_involved in_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Elevated serum creatinine::HP:0003259_has phenotype_NFE2L2::NCBIGene:4780	28
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	NFE2L2::NCBIGene:4780_in 1 to 1 orthology relationship with_Nfe2l2::RGD:620360	24
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Cav1::MGI:102709_in 1 to 1 orthology relationship with_Cav1::RGD:2280	24
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Cav1::RGD:2280_None_response to estrogen::GO:0043627	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_renal water absorption::GO:0070295	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	renal water absorption::GO:0070295_involved in_AQP1::NCBIGene:358	44
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_carbon dioxide transmembrane transporter activity::GO:0035379	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_cell volume homeostasis::GO:0006884	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_camera-type eye morphogenesis::GO:0048593	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp3::MGI:1333777_has phenotype_Gastrointestinal hemorrhage::HP:0002239	28
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Gastrointestinal hemorrhage::HP:0002239_has phenotype_NFE2L2::NCBIGene:4780	28
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	NFE2L2::NCBIGene:4780_in 1 to 1 orthology relationship with_Nfe2l2::MGI:108420	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Nfe2l2::MGI:108420_involved in_cellular response to hydrogen peroxide::GO:0070301	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	hearing/vestibular/ear phenotype::MP:0005377_has phenotype_Aqp5::MGI:106215	40
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	decreased urine osmolality::MP:0002988_has phenotype_Aqp11::MGI:1913583	4
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp11::MGI:1913583_in 1 to 1 orthology relationship with_Aqp11::RGD:628763	16
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp11::RGD:628763_None_glycerol transport::GO:0015793	16
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_secretory granule organization::GO:0033363	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	secretory granule organization::GO:0033363_involved in_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	increased susceptibility to induced colitis::MP:0008537_has phenotype_Elavl1::MGI:1100851	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Elavl1::MGI:1100851_in 1 to 1 orthology relationship with_elavl1a::ZFIN:ZDB-GENE-990415-245	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	elavl1a::ZFIN:ZDB-GENE-990415-245_involved in_positive regulation of angiogenesis::GO:0045766	4
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_transepithelial water transport::GO:0035377	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	transepithelial water transport::GO:0035377_involved in_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_nitric oxide transport::GO:0030185	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	nitric oxide transport::GO:0030185_involved in_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp2::MGI:1096865_None_cellular response to mercury ion::GO:0071288	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	AQP2::NCBIGene:359_in 1 to 1 orthology relationship with_Aqp2::RGD:2142	40
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp5::MGI:106215_in 1 to 1 orthology relationship with_Aqp5::RGD:2144	40
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp5::RGD:2144_None_carbon dioxide transport::GO:0015670	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	aqp1a.1::ZFIN:ZDB-GENE-030131-7764_involved in_carbon dioxide transport::GO:0015670	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	AQP2::NCBIGene:359_involved in_renal water transport::GO:0003097	20
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp4::RGD:2143_None_hyperosmotic salinity response::GO:0042538	12
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Polyuria::HP:0000103_has phenotype_Avp::MGI:88121	28
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	AVP::NCBIGene:551_involved in_negative regulation of apoptotic process::GO:0043066	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	negative regulation of apoptotic process::GO:0043066_involved in_AQP1::NCBIGene:358	16
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Nfe2l2::RGD:620360_None_cellular response to hydrogen peroxide::GO:0070301	12
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_positive regulation of fibroblast proliferation::GO:0048146	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	positive regulation of fibroblast proliferation::GO:0048146_involved in_AQP1::NCBIGene:358	44
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp2::MGI:1096865_involved in_cell volume homeostasis::GO:0006884	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_cellular response to dexamethasone stimulus::GO:0071549	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	aqp1a.1::ZFIN:ZDB-GENE-030131-7764_None_carbon dioxide transmembrane transporter activity::GO:0035379	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp2::RGD:2142_None_glycerol transport::GO:0015793	28
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_sensory perception of pain::GO:0019233	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	sensory perception of pain::GO:0019233_involved in_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	AQP4::NCBIGene:361_involved in_renal water homeostasis::GO:0003091	12
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp2::RGD:2142_None_cellular response to copper ion::GO:0071280	28
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	cellular response to copper ion::GO:0071280_involved in_AQP1::NCBIGene:358	96
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_glycerol transport::GO:0015793	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_metanephric proximal convoluted tubule segment 2 development::GO:0072232	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	metanephric proximal convoluted tubule segment 2 development::GO:0072232_involved in_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_renal water transport::GO:0003097	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_carbon dioxide transmembrane transport::GO:0035378	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	carbon dioxide transmembrane transport::GO:0035378_involved in_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Polydipsia::HP:0001959_has phenotype_Aqp2::MGI:1096865	40
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	AQP2::NCBIGene:359_involved in_cellular response to copper ion::GO:0071280	20
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_cellular response to copper ion::GO:0071280	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp2::RGD:2142_None_cellular response to mercury ion::GO:0071288	28
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_metanephric glomerulus vasculature development::GO:0072239	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	metanephric glomerulus vasculature development::GO:0072239_involved in_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	abnormal renal water transport::MP:0011443_has phenotype_Aqp4::MGI:107387	36
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp4::RGD:2143_None_sarcolemma::GO:0042383	12
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Avp::MGI:88121_None_multicellular organismal water homeostasis::GO:0050891	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Nfe2l2::MGI:108420_None_cellular response to hydrogen peroxide::GO:0070301	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_cellular response to cAMP::GO:0071320	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	cellular response to cAMP::GO:0071320_involved in_AQP1::NCBIGene:358	40
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Polydipsia::HP:0001959_has phenotype_AQP2::NCBIGene:359	60
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Egfr::RGD:2543_None_cellular response to mechanical stimulus::GO:0071260	12
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_symbiont-containing vacuole::GO:0020003	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	symbiont-containing vacuole::GO:0020003_is part of_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp4::RGD:2143_None_renal water absorption::GO:0070295	12
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_nitric oxide transmembrane transporter activity::GO:0030184	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	nitric oxide transmembrane transporter activity::GO:0030184_enables_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Increased blood urea nitrogen::HP:0003138_has phenotype_Egfr::MGI:95294	24
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	EGFR::NCBIGene:1956_is part of_nuclear membrane::GO:0031965	12
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	nuclear membrane::GO:0031965_is part of_AQP1::NCBIGene:358	12
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Egfr::RGD:2543_None_positive regulation of fibroblast proliferation::GO:0048146	12
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp3::MGI:1333777_has phenotype_Hypotriglyceridemia::HP:0012153	4
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Hypotriglyceridemia::HP:0012153_has phenotype_Aqp11::MGI:1913583	4
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_negative regulation of cysteine-type endopeptidase activity involved in apoptotic process::GO:0043154	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Avp::RGD:2184_None_negative regulation of cysteine-type endopeptidase activity involved in apoptotic process::GO:0043154	16
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Nfe2l2::MGI:108420_involved in_positive regulation of angiogenesis::GO:0045766	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	increased sensitivity to induced morbidity/mortality::MP:0009763_has phenotype_Cav1::MGI:102709	16
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Nfe2l2::MGI:108420_None_positive regulation of angiogenesis::GO:0045766	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Cav1::RGD:2280_None_basal plasma membrane::GO:0009925	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp2::MGI:1096865_involved in_cellular response to mercury ion::GO:0071288	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp5::RGD:2144_None_pancreatic juice secretion::GO:0030157	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp5::RGD:2144_None_odontogenesis::GO:0042476	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Increased blood urea nitrogen::HP:0003138_has phenotype_App::MGI:88059	4
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	App::MGI:88059_in 1 to 1 orthology relationship with_App::RGD:2139	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	App::RGD:2139_None_cellular response to cAMP::GO:0071320	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	AQP5::NCBIGene:362_is part of_basal plasma membrane::GO:0009925	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	EGFR::NCBIGene:1956_involved in_cellular response to dexamethasone stimulus::GO:0071549	12
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Nfe2l2::MGI:108420_in 1 to 1 orthology relationship with_NFE2L2::NCBIGene:4780	12
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	NFE2L2::NCBIGene:4780_involved in_positive regulation of angiogenesis::GO:0045766	4
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Avp::MGI:88121_involved in_multicellular organismal water homeostasis::GO:0050891	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	AQP4::NCBIGene:361_involved in_multicellular organismal water homeostasis::GO:0050891	12
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_cellular response to mercury ion::GO:0071288	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp2::MGI:1096865_involved in_cellular response to copper ion::GO:0071280	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp5::RGD:2144_None_basal plasma membrane::GO:0009925	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_basal plasma membrane::GO:0009925	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp1::RGD:2141_None_cellular response to salt stress::GO:0071472	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	cellular response to salt stress::GO:0071472_involved in_AQP1::NCBIGene:358	32
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	AVP::NCBIGene:551_involved in_negative regulation of cysteine-type endopeptidase activity involved in apoptotic process::GO:0043154	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Nfe2l2::RGD:620360_None_cellular response to hypoxia::GO:0071456	12
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Cav1::RGD:2280_None_cellular response to mechanical stimulus::GO:0071260	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Avp::MGI:88121_involved in_negative regulation of apoptotic process::GO:0043066	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	AQP5::NCBIGene:362_involved in_odontogenesis::GO:0042476	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp4::RGD:2143_None_multicellular organismal water homeostasis::GO:0050891	12
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp2::MGI:1096865_None_cellular response to copper ion::GO:0071280	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp2::MGI:1096865_None_glycerol transport::GO:0015793	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp2::MGI:1096865_involved in_renal water transport::GO:0003097	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Avp::MGI:88121_involved in_negative regulation of cysteine-type endopeptidase activity involved in apoptotic process::GO:0043154	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	AVP::NCBIGene:551_involved in_hyperosmotic salinity response::GO:0042538	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp4::RGD:2143_None_carbon dioxide transport::GO:0015670	12
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp2::MGI:1096865_None_renal water transport::GO:0003097	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	NFE2L2::NCBIGene:4780_involved in_cellular response to hydrogen peroxide::GO:0070301	4
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	increased sensitivity to induced morbidity/mortality::MP:0009763_has phenotype_Fos::MGI:95574	4
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Fos::MGI:95574_in 1 to 1 orthology relationship with_FOS::NCBIGene:2353	4
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	FOS::NCBIGene:2353_involved in_response to drug::GO:0042493	4
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	response to drug::GO:0042493_involved in_AQP1::NCBIGene:358	4
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp5::RGD:2144_None_camera-type eye morphogenesis::GO:0048593	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	AQP5::NCBIGene:362_involved in_carbon dioxide transport::GO:0015670	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp2::MGI:1096865_None_cell volume homeostasis::GO:0006884	8
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Elevated serum creatinine::HP:0003259_has phenotype_Aqp11::MGI:1913583	4
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Aqp3::MGI:1333777_has phenotype_abnormal olfactory epithelium morphology::MP:0008789	4
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	abnormal olfactory epithelium morphology::MP:0008789_has phenotype_App::MGI:88059	4
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	Increased blood urea nitrogen::HP:0003138_has phenotype_Aqp11::MGI:1913583	4
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	NFE2L2::NCBIGene:4780_involved in_cellular response to hypoxia::GO:0071456	4
AQP3::NCBIGene:360	AQP1::NCBIGene:358	2864	elavl1a::ZFIN:ZDB-GENE-990415-245_None_positive regulation of angiogenesis::GO:0045766	4
AQP3::NCBIGene:360	Aqp1::NCBIGene:11826	0	NA	0
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	AQP3::NCBIGene:360_in 1 to 1 orthology relationship with_Aqp3::MGI:1333777	184
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Aqp3::MGI:1333777_has phenotype_Gastrointestinal hemorrhage::HP:0002239	28
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Gastrointestinal hemorrhage::HP:0002239_has phenotype_NFE2L2::NCBIGene:4780	28
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	NFE2L2::NCBIGene:4780_in 1 to 1 orthology relationship with_Nfe2l2::MGI:108420	48
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Nfe2l2::MGI:108420_None_RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980	8
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980_enables_NFE2L1::NCBIGene:4779	64
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Aqp3::MGI:1333777_has phenotype_decreased bone mineral content::MP:0010124	24
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	decreased bone mineral content::MP:0010124_has phenotype_Bach2::MGI:894679	24
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Bach2::MGI:894679_in 1 to 1 orthology relationship with_BACH2::NCBIGene:60468	16
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	BACH2::NCBIGene:60468_enables_RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980	8
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Aqp3::MGI:1333777_has phenotype_increased susceptibility to induced colitis::MP:0008537	36
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	increased susceptibility to induced colitis::MP:0008537_has phenotype_Nfe2l2::MGI:108420	36
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Nfe2l2::MGI:108420_in 1 to 1 orthology relationship with_Nfe2l2::RGD:620360	4
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Nfe2l2::RGD:620360_None_RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980	12
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Aqp3::MGI:1333777_has phenotype_Elevated serum creatinine::HP:0003259	36
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Elevated serum creatinine::HP:0003259_has phenotype_NFE2L2::NCBIGene:4780	28
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Nfe2l2::MGI:108420_enables_transcription regulatory region sequence-specific DNA binding::GO:0000976	8
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	transcription regulatory region sequence-specific DNA binding::GO:0000976_enables_NFE2L1::NCBIGene:4779	24
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Nfe2l2::MGI:108420_in 1 to 1 orthology relationship with_NFE2L2::NCBIGene:4780	24
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	NFE2L2::NCBIGene:4780_involved in_inflammatory response::GO:0006954	4
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	inflammatory response::GO:0006954_involved in_NFE2L1::NCBIGene:4779	16
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	NFE2L2::NCBIGene:4780_enables_protein domain specific binding::GO:0019904	4
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	protein domain specific binding::GO:0019904_enables_NFE2L1::NCBIGene:4779	12
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Nfe2l2::MGI:108420_in 1 to 1 orthology relationship with_nfe2l2a::ZFIN:ZDB-GENE-030723-2	8
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	nfe2l2a::ZFIN:ZDB-GENE-030723-2_involved in_cellular response to oxidative stress::GO:0034599	4
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	cellular response to oxidative stress::GO:0034599_involved in_NFE2L1::NCBIGene:4779	20
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Aqp3::MGI:1333777_has phenotype_Osteopenia::HP:0000938	24
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Osteopenia::HP:0000938_has phenotype_Bach2::MGI:894679	24
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Nfe2l2::MGI:108420_enables_RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980	8
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Nfe2l2::MGI:108420_involved in_inflammatory response::GO:0006954	8
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Aqp3::MGI:1333777_has phenotype_increased sensitivity to induced morbidity/mortality::MP:0009763	28
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	increased sensitivity to induced morbidity/mortality::MP:0009763_has phenotype_Nfe2::MGI:97308	12
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Nfe2::MGI:97308_in 1 to 1 orthology relationship with_nfe2::ZFIN:ZDB-GENE-030124-1	8
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	nfe2::ZFIN:ZDB-GENE-030124-1_enables_transcription regulatory region sequence-specific DNA binding::GO:0000976	4
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	NFE2L2::NCBIGene:4780_in 1 to 1 orthology relationship with_Nfe2l2::RGD:620360	8
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Aqp3::MGI:1333777_has phenotype_Increased blood urea nitrogen::HP:0003138	8
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Increased blood urea nitrogen::HP:0003138_has phenotype_Egfr::MGI:95294	4
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Egfr::MGI:95294_in 1 to 1 orthology relationship with_EGFR::NCBIGene:1956	12
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	EGFR::NCBIGene:1956_is part of_endoplasmic reticulum membrane::GO:0005789	12
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	endoplasmic reticulum membrane::GO:0005789_is part of_NFE2L1::NCBIGene:4779	20
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Nfe2l2::MGI:108420_involved in_cellular response to oxidative stress::GO:0034599	8
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Bach2::MGI:894679_in 1 to 1 orthology relationship with_bach2b::ZFIN:ZDB-GENE-041001-139	24
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	bach2b::ZFIN:ZDB-GENE-041001-139_enables_RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980	8
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Bach2::MGI:894679_in 1 to 1 orthology relationship with_Bach2::RGD:1562865	8
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Bach2::RGD:1562865_None_RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980	8
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	NFE2L2::NCBIGene:4780_enables_transcription regulatory region sequence-specific DNA binding::GO:0000976	4
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Nfe2l2::MGI:108420_enables_protein domain specific binding::GO:0019904	8
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	increased sensitivity to induced morbidity/mortality::MP:0009763_has phenotype_Egfr::MGI:95294	4
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	increased sensitivity to induced morbidity/mortality::MP:0009763_has phenotype_Cav1::MGI:102709	4
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Cav1::MGI:102709_in 1 to 1 orthology relationship with_CAV1::NCBIGene:857	8
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	CAV1::NCBIGene:857_is part of_endoplasmic reticulum membrane::GO:0005789	8
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Elevated serum creatinine::HP:0003259_has phenotype_Egfr::MGI:95294	4
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	BACH2::NCBIGene:60468_involved in_transcription from RNA polymerase II promoter::GO:0006366	8
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	transcription from RNA polymerase II promoter::GO:0006366_involved in_NFE2L1::NCBIGene:4779	28
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	NFE2L2::NCBIGene:4780_enables_RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980	4
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Elevated serum creatinine::HP:0003259_has phenotype_Ikzf3::MGI:1342542	4
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Ikzf3::MGI:1342542_in 1 to 1 orthology relationship with_IKZF3::NCBIGene:22806	4
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	IKZF3::NCBIGene:22806_involved in_transcription from RNA polymerase II promoter::GO:0006366	4
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	bach2b::ZFIN:ZDB-GENE-041001-139_None_RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980	8
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	bach2b::ZFIN:ZDB-GENE-041001-139_involved in_transcription from RNA polymerase II promoter::GO:0006366	8
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Increased blood urea nitrogen::HP:0003138_has phenotype_Cav1::MGI:102709	4
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	NFE2L2::NCBIGene:4780_involved in_cellular response to oxidative stress::GO:0034599	4
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	NFE2L2::NCBIGene:4780_involved in_transcription from RNA polymerase II promoter::GO:0006366	4
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	increased sensitivity to induced morbidity/mortality::MP:0009763_has phenotype_Fos::MGI:95574	8
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Fos::MGI:95574_in 1 to 1 orthology relationship with_FOS::NCBIGene:2353	8
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	FOS::NCBIGene:2353_involved in_transcription from RNA polymerase II promoter::GO:0006366	4
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	Nfe2::MGI:97308_in 1 to 1 orthology relationship with_NFE2::NCBIGene:4778	4
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	NFE2::NCBIGene:4778_enables_transcription regulatory region sequence-specific DNA binding::GO:0000976	4
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	nfe2::ZFIN:ZDB-GENE-030124-1_involved in_cellular response to oxidative stress::GO:0034599	4
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	FOS::NCBIGene:2353_involved in_inflammatory response::GO:0006954	4
AQP3::NCBIGene:360	NFE2L1::NCBIGene:4779	184	nfe2l2a::ZFIN:ZDB-GENE-030723-2_enables_transcription regulatory region sequence-specific DNA binding::GO:0000976	4
AQP3::NCBIGene:360	ENGASE::NCBIGene:64772	8	AQP3::NCBIGene:360_in 1 to 1 orthology relationship with_Aqp3::MGI:1333777	8
AQP3::NCBIGene:360	ENGASE::NCBIGene:64772	8	Aqp3::MGI:1333777_has phenotype_Polydipsia::HP:0001959	4
AQP3::NCBIGene:360	ENGASE::NCBIGene:64772	8	Polydipsia::HP:0001959_has phenotype_AQP2::NCBIGene:359	4
AQP3::NCBIGene:360	ENGASE::NCBIGene:64772	8	AQP2::NCBIGene:359_in 1 to 1 orthology relationship with_Aqp2::MGI:1096865	8
AQP3::NCBIGene:360	ENGASE::NCBIGene:64772	8	Aqp2::MGI:1096865_is part of_lysosome::GO:0005764	8
AQP3::NCBIGene:360	ENGASE::NCBIGene:64772	8	lysosome::GO:0005764_is part of_ENGASE::NCBIGene:64772	8
AQP3::NCBIGene:360	ENGASE::NCBIGene:64772	8	Aqp3::MGI:1333777_has phenotype_Polyuria::HP:0000103	4
AQP3::NCBIGene:360	ENGASE::NCBIGene:64772	8	Polyuria::HP:0000103_has phenotype_AQP2::NCBIGene:359	4
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	AQP3::NCBIGene:360_in 1 to 1 orthology relationship with_Aqp3::MGI:1333777	68
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	Aqp3::MGI:1333777_has phenotype_increased sensitivity to induced morbidity/mortality::MP:0009763	8
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	increased sensitivity to induced morbidity/mortality::MP:0009763_has phenotype_Cav1::MGI:102709	4
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	Cav1::MGI:102709_in 1 to 1 orthology relationship with_CAV1::NCBIGene:857	8
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	CAV1::NCBIGene:857_involved in_protein homooligomerization::GO:0051260	8
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	protein homooligomerization::GO:0051260_involved in_AQP11::NCBIGene:282679	8
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	Aqp3::MGI:1333777_has phenotype_Increased blood urea nitrogen::HP:0003138	16
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	Increased blood urea nitrogen::HP:0003138_has phenotype_Aqp11::MGI:1913583	8
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	Aqp11::MGI:1913583_in 1 to 1 orthology relationship with_Aqp11::RGD:628763	32
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	Aqp11::RGD:628763_None_endosomal lumen acidification::GO:0048388	16
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	endosomal lumen acidification::GO:0048388_involved in_AQP11::NCBIGene:282679	16
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	Aqp3::MGI:1333777_has phenotype_decreased urine osmolality::MP:0002988	12
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	decreased urine osmolality::MP:0002988_has phenotype_Aqp11::MGI:1913583	8
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	Aqp11::RGD:628763_None_proximal tubule development::GO:0072014	16
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	proximal tubule development::GO:0072014_involved in_AQP11::NCBIGene:282679	16
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	Aqp3::MGI:1333777_has phenotype_Hypotriglyceridemia::HP:0012153	8
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	Hypotriglyceridemia::HP:0012153_has phenotype_Aqp11::MGI:1913583	8
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	Aqp3::MGI:1333777_has phenotype_Elevated serum creatinine::HP:0003259	12
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	Elevated serum creatinine::HP:0003259_has phenotype_Aqp11::MGI:1913583	8
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	increased sensitivity to induced morbidity/mortality::MP:0009763_has phenotype_Egfr::MGI:95294	4
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	Egfr::MGI:95294_in 1 to 1 orthology relationship with_EGFR::NCBIGene:1956	12
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	EGFR::NCBIGene:1956_is part of_cell surface::GO:0009986	12
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	cell surface::GO:0009986_is part of_AQP11::NCBIGene:282679	12
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	Aqp3::MGI:1333777_has phenotype_Osteopenia::HP:0000938	4
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	Osteopenia::HP:0000938_has phenotype_AVP::NCBIGene:551	4
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	AVP::NCBIGene:551_in 1 to 1 orthology relationship with_Avp::MGI:88121	8
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	Avp::MGI:88121_is part of_dendrite::GO:0030425	8
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	dendrite::GO:0030425_is part of_AQP11::NCBIGene:282679	16
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	Elevated serum creatinine::HP:0003259_has phenotype_Egfr::MGI:95294	4
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	Aqp3::MGI:1333777_has phenotype_Polyuria::HP:0000103	4
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	Polyuria::HP:0000103_has phenotype_Avp::MGI:88121	4
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	Avp::MGI:88121_in 1 to 1 orthology relationship with_AVP::NCBIGene:551	8
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	AVP::NCBIGene:551_is part of_dendrite::GO:0030425	8
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	Increased blood urea nitrogen::HP:0003138_has phenotype_Egfr::MGI:95294	4
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	decreased urine osmolality::MP:0002988_has phenotype_Avp::MGI:88121	4
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	Increased blood urea nitrogen::HP:0003138_has phenotype_Cav1::MGI:102709	4
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	Aqp3::MGI:1333777_has phenotype_Polydipsia::HP:0001959	4
AQP3::NCBIGene:360	AQP11::NCBIGene:282679	68	Polydipsia::HP:0001959_has phenotype_AVP::NCBIGene:551	4
AQP11::NCBIGene:282679	NGLY1::NCBIGene:55768	24	AQP11::NCBIGene:282679_in 1 to 1 orthology relationship with_Aqp11::MGI:1913583	24
AQP11::NCBIGene:282679	NGLY1::NCBIGene:55768	24	Aqp11::MGI:1913583_has phenotype_premature death::MP:0002083	16
AQP11::NCBIGene:282679	NGLY1::NCBIGene:55768	24	premature death::MP:0002083_has phenotype_Rad23b::MGI:105128	8
AQP11::NCBIGene:282679	NGLY1::NCBIGene:55768	24	Rad23b::MGI:105128_in 1 to 1 orthology relationship with_RAD23B::NCBIGene:5887	8
AQP11::NCBIGene:282679	NGLY1::NCBIGene:55768	24	RAD23B::NCBIGene:5887_involved in_protein folding::GO:0006457	4
AQP11::NCBIGene:282679	NGLY1::NCBIGene:55768	24	protein folding::GO:0006457_involved in_NGLY1::NCBIGene:55768	12
AQP11::NCBIGene:282679	NGLY1::NCBIGene:55768	24	Aqp11::MGI:1913583_has phenotype_abnormal hepatocyte morphology::MP:0000607	8
AQP11::NCBIGene:282679	NGLY1::NCBIGene:55768	24	abnormal hepatocyte morphology::MP:0000607_has phenotype_Amfr::MGI:1345634	8
AQP11::NCBIGene:282679	NGLY1::NCBIGene:55768	24	Amfr::MGI:1345634_in 1 to 1 orthology relationship with_AMFR::NCBIGene:267	8
AQP11::NCBIGene:282679	NGLY1::NCBIGene:55768	24	AMFR::NCBIGene:267_involved in_protein folding::GO:0006457	4
AQP11::NCBIGene:282679	NGLY1::NCBIGene:55768	24	RAD23B::NCBIGene:5887_Source_Deglycosylation complex hydrolyses N-glycans from unfolded glycoproteins::REACT:R-HSA-8850594	4
AQP11::NCBIGene:282679	NGLY1::NCBIGene:55768	24	Deglycosylation complex hydrolyses N-glycans from unfolded glycoproteins::REACT:R-HSA-8850594_Source_NGLY1::NCBIGene:55768	12
AQP11::NCBIGene:282679	NGLY1::NCBIGene:55768	24	premature death::MP:0002083_has phenotype_Psmc1::MGI:106054	8
AQP11::NCBIGene:282679	NGLY1::NCBIGene:55768	24	Psmc1::MGI:106054_in 1 to 1 orthology relationship with_PSMC1::NCBIGene:5700	8
AQP11::NCBIGene:282679	NGLY1::NCBIGene:55768	24	PSMC1::NCBIGene:5700_involved in_protein folding::GO:0006457	4
AQP11::NCBIGene:282679	NGLY1::NCBIGene:55768	24	PSMC1::NCBIGene:5700_Source_Deglycosylation complex hydrolyses N-glycans from unfolded glycoproteins::REACT:R-HSA-8850594	4
AQP11::NCBIGene:282679	NGLY1::NCBIGene:55768	24	AMFR::NCBIGene:267_Source_Deglycosylation complex hydrolyses N-glycans from unfolded glycoproteins::REACT:R-HSA-8850594	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	AQP11::NCBIGene:282679_in 1 to 1 orthology relationship with_Aqp11::MGI:1913583	1028
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp11::MGI:1913583_has phenotype_decreased urine osmolality::MP:0002988	392
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	decreased urine osmolality::MP:0002988_has phenotype_Aqp3::MGI:1333777	36
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp3::MGI:1333777_in 1 to 1 orthology relationship with_AQP3::NCBIGene:360	80
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	AQP3::NCBIGene:360_involved in_cellular response to hypoxia::GO:0071456	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	cellular response to hypoxia::GO:0071456_involved in_AQP1::NCBIGene:358	60
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp3::MGI:1333777_in 1 to 1 orthology relationship with_Aqp3::RGD:68428	64
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp3::RGD:68428_None_renal water absorption::GO:0070295	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	renal water absorption::GO:0070295_involved in_AQP1::NCBIGene:358	48
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp11::MGI:1913583_has phenotype_abnormal proximal convoluted tubule morphology::MP:0004756	12
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	abnormal proximal convoluted tubule morphology::MP:0004756_has phenotype_Gsk3b::MGI:1861437	12
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Gsk3b::MGI:1861437_in 1 to 1 orthology relationship with_GSK3B::NCBIGene:2932	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	GSK3B::NCBIGene:2932_involved in_negative regulation of apoptotic process::GO:0043066	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	negative regulation of apoptotic process::GO:0043066_involved in_AQP1::NCBIGene:358	24
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	decreased urine osmolality::MP:0002988_has phenotype_Aqp2::MGI:1096865	40
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp2::MGI:1096865_in 1 to 1 orthology relationship with_AQP2::NCBIGene:359	60
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	AQP2::NCBIGene:359_involved in_renal water homeostasis::GO:0003091	12
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	renal water homeostasis::GO:0003091_involved in_AQP1::NCBIGene:358	40
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	decreased urine osmolality::MP:0002988_has phenotype_Aqp1::MGI:103201	252
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::MGI:103201_in 1 to 1 orthology relationship with_Aqp1::RGD:2141	228
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_multicellular organismal water homeostasis::GO:0050891	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	multicellular organismal water homeostasis::GO:0050891_involved in_AQP1::NCBIGene:358	24
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp11::MGI:1913583_has phenotype_homeostasis/metabolism phenotype::MP:0005376	132
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Nfe2l2::MGI:108420	24
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Nfe2l2::MGI:108420_in 1 to 1 orthology relationship with_NFE2L2::NCBIGene:4780	24
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	NFE2L2::NCBIGene:4780_involved in_cellular response to hypoxia::GO:0071456	8
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp11::MGI:1913583_has phenotype_Increased blood urea nitrogen::HP:0003138	120
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Increased blood urea nitrogen::HP:0003138_has phenotype_Cav1::MGI:102709	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Cav1::MGI:102709_in 1 to 1 orthology relationship with_Cav1::RGD:2280	48
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Cav1::RGD:2280_None_cellular response to mechanical stimulus::GO:0071260	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	cellular response to mechanical stimulus::GO:0071260_involved in_AQP1::NCBIGene:358	56
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp11::MGI:1913583_has phenotype_Elevated serum creatinine::HP:0003259	88
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Elevated serum creatinine::HP:0003259_has phenotype_Egfr::MGI:95294	24
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Egfr::MGI:95294_in 1 to 1 orthology relationship with_Egfr::RGD:2543	60
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Egfr::RGD:2543_None_cellular response to mechanical stimulus::GO:0071260	20
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp11::MGI:1913583_has phenotype_Leukopenia::HP:0001882	60
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Leukopenia::HP:0001882_has phenotype_Egfr::MGI:95294	24
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Egfr::MGI:95294_in 1 to 1 orthology relationship with_EGFR::NCBIGene:1956	60
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	EGFR::NCBIGene:1956_involved in_cellular response to dexamethasone stimulus::GO:0071549	20
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	cellular response to dexamethasone stimulus::GO:0071549_involved in_AQP1::NCBIGene:358	44
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp11::MGI:1913583_has phenotype_premature death::MP:0002083	108
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	premature death::MP:0002083_has phenotype_Car12::MGI:1923709	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Car12::MGI:1923709_in 1 to 1 orthology relationship with_CA12::NCBIGene:771	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	CA12::NCBIGene:771_involved in_bicarbonate transport::GO:0015701	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	bicarbonate transport::GO:0015701_involved in_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_metanephric descending thin limb development::GO:0072220	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	metanephric descending thin limb development::GO:0072220_involved in_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Elevated serum creatinine::HP:0003259_has phenotype_Aqp3::MGI:1333777	36
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp11::MGI:1913583_has phenotype_decreased circulating glycerol level::MP:0003442	32
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	decreased circulating glycerol level::MP:0003442_has phenotype_Cav1::MGI:102709	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Leukopenia::HP:0001882_has phenotype_NFE2L2::NCBIGene:4780	28
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	NFE2L2::NCBIGene:4780_in 1 to 1 orthology relationship with_Nfe2l2::MGI:108420	32
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Nfe2l2::MGI:108420_involved in_positive regulation of angiogenesis::GO:0045766	8
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	positive regulation of angiogenesis::GO:0045766_involved in_AQP1::NCBIGene:358	60
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::MGI:103201_in 1 to 1 orthology relationship with_aqp1a.1::ZFIN:ZDB-GENE-030131-7764	24
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	aqp1a.1::ZFIN:ZDB-GENE-030131-7764_None_carbon dioxide transmembrane transporter activity::GO:0035379	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	carbon dioxide transmembrane transporter activity::GO:0035379_enables_AQP1::NCBIGene:358	12
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Cav1::MGI:102709	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Cav1::RGD:2280_None_response to estrogen::GO:0043627	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	response to estrogen::GO:0043627_involved in_AQP1::NCBIGene:358	36
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Egfr::RGD:2543_None_cellular response to dexamethasone stimulus::GO:0071549	20
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_camera-type eye morphogenesis::GO:0048593	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	camera-type eye morphogenesis::GO:0048593_involved in_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Increased blood urea nitrogen::HP:0003138_has phenotype_Aqp2::MGI:1096865	40
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp2::MGI:1096865_in 1 to 1 orthology relationship with_Aqp2::RGD:2142	60
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp2::RGD:2142_None_renal water transport::GO:0003097	12
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	renal water transport::GO:0003097_involved in_AQP1::NCBIGene:358	28
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Leukopenia::HP:0001882_has phenotype_Elavl1::MGI:1100851	8
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Elavl1::MGI:1100851_in 1 to 1 orthology relationship with_elavl1a::ZFIN:ZDB-GENE-990415-245	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	elavl1a::ZFIN:ZDB-GENE-990415-245_involved in_positive regulation of angiogenesis::GO:0045766	8
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Nfe2l2::MGI:108420_None_positive regulation of angiogenesis::GO:0045766	8
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	AQP3::NCBIGene:360_involved in_renal water homeostasis::GO:0003091	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_carbon dioxide transport::GO:0015670	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	carbon dioxide transport::GO:0015670_involved in_AQP1::NCBIGene:358	20
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	premature death::MP:0002083_has phenotype_Aqp2::MGI:1096865	40
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp2::RGD:2142_None_cell volume homeostasis::GO:0006884	12
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	cell volume homeostasis::GO:0006884_involved in_AQP1::NCBIGene:358	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_carbon dioxide transmembrane transporter activity::GO:0035379	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	AQP2::NCBIGene:359_involved in_cellular response to mercury ion::GO:0071288	12
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	cellular response to mercury ion::GO:0071288_involved in_AQP1::NCBIGene:358	28
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Increased blood urea nitrogen::HP:0003138_has phenotype_Aqp3::MGI:1333777	36
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp3::RGD:68428_None_cellular response to hypoxia::GO:0071456	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Gsk3b::MGI:1861437_in 1 to 1 orthology relationship with_Gsk3b::RGD:70982	32
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Gsk3b::RGD:70982_None_cellular response to mechanical stimulus::GO:0071260	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_secretory granule organization::GO:0033363	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	secretory granule organization::GO:0033363_involved in_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	decreased urine osmolality::MP:0002988_has phenotype_Avp::MGI:88121	28
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Avp::MGI:88121_in 1 to 1 orthology relationship with_AVP::NCBIGene:551	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	AVP::NCBIGene:551_involved in_renal water homeostasis::GO:0003091	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	premature death::MP:0002083_has phenotype_Fbxw7::MGI:1354695	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Fbxw7::MGI:1354695_in 1 to 1 orthology relationship with_Fbxw7::RGD:2321145	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Fbxw7::RGD:2321145_None_cellular response to UV::GO:0034644	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	cellular response to UV::GO:0034644_involved in_AQP1::NCBIGene:358	8
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp11::MGI:1913583_has phenotype_abnormal hepatocyte morphology::MP:0000607	36
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	abnormal hepatocyte morphology::MP:0000607_has phenotype_Egfr::MGI:95294	24
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	EGFR::NCBIGene:1956_is part of_nuclear membrane::GO:0031965	20
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	nuclear membrane::GO:0031965_is part of_AQP1::NCBIGene:358	20
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Increased blood urea nitrogen::HP:0003138_has phenotype_Egfr::MGI:95294	24
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_brush border membrane::GO:0031526	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	brush border membrane::GO:0031526_is part of_AQP1::NCBIGene:358	8
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	AQP3::NCBIGene:360_involved in_renal water absorption::GO:0070295	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Elevated serum creatinine::HP:0003259_has phenotype_NFE2L2::NCBIGene:4780	28
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Nfe2l2::MGI:108420_None_cellular response to hydrogen peroxide::GO:0070301	8
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	cellular response to hydrogen peroxide::GO:0070301_involved in_AQP1::NCBIGene:358	60
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Aqp4::MGI:107387	36
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp4::MGI:107387_in 1 to 1 orthology relationship with_Aqp4::RGD:2143	48
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp4::RGD:2143_None_carbon dioxide transport::GO:0015670	8
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_cellular response to nitric oxide::GO:0071732	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	cellular response to nitric oxide::GO:0071732_involved in_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	AQP2::NCBIGene:359_involved in_glycerol transport::GO:0015793	12
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	glycerol transport::GO:0015793_involved in_AQP1::NCBIGene:358	68
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	AQP2::NCBIGene:359_involved in_renal water transport::GO:0003097	12
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	abnormal hepatocyte morphology::MP:0000607_has phenotype_Gsk3b::MGI:1861437	12
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Gsk3b::RGD:70982_None_cellular response to hydrogen peroxide::GO:0070301	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	AQP2::NCBIGene:359_involved in_cellular response to copper ion::GO:0071280	12
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	cellular response to copper ion::GO:0071280_involved in_AQP1::NCBIGene:358	28
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_metanephric proximal straight tubule development::GO:0072230	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	metanephric proximal straight tubule development::GO:0072230_involved in_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_ephrin receptor binding::GO:0046875	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	ephrin receptor binding::GO:0046875_enables_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	premature death::MP:0002083_has phenotype_Elavl1::MGI:1100851	8
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_negative regulation of cysteine-type endopeptidase activity involved in apoptotic process::GO:0043154	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	negative regulation of cysteine-type endopeptidase activity involved in apoptotic process::GO:0043154_involved in_AQP1::NCBIGene:358	12
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	NFE2L2::NCBIGene:4780_involved in_cellular response to hydrogen peroxide::GO:0070301	8
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	elavl1a::ZFIN:ZDB-GENE-990415-245_None_positive regulation of angiogenesis::GO:0045766	8
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp11::MGI:1913583_has phenotype_Hypotriglyceridemia::HP:0012153	36
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Hypotriglyceridemia::HP:0012153_has phenotype_Aqp3::MGI:1333777	36
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp3::RGD:68428_None_glycerol transport::GO:0015793	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp11::MGI:1913583_has phenotype_abnormal renal tubule morphology::MP:0002703	12
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	abnormal renal tubule morphology::MP:0002703_has phenotype_Gsk3b::MGI:1861437	12
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp3::RGD:68428_None_odontogenesis::GO:0042476	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	odontogenesis::GO:0042476_involved in_AQP1::NCBIGene:358	36
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_intracellular cGMP activated cation channel activity::GO:0005223	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	intracellular cGMP activated cation channel activity::GO:0005223_enables_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	EGFR::NCBIGene:1956_involved in_wound healing::GO:0042060	20
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	wound healing::GO:0042060_involved in_AQP1::NCBIGene:358	20
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_hyperosmotic salinity response::GO:0042538	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	hyperosmotic salinity response::GO:0042538_involved in_AQP1::NCBIGene:358	20
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Gsk3b::MGI:1861437	12
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_cellular response to hydrogen peroxide::GO:0070301	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp2::RGD:2142_None_cellular response to mercury ion::GO:0071288	12
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_renal water transport::GO:0003097	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_cerebrospinal fluid secretion::GO:0033326	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	cerebrospinal fluid secretion::GO:0033326_involved in_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	NFE2L2::NCBIGene:4780_in 1 to 1 orthology relationship with_Nfe2l2::RGD:620360	24
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Nfe2l2::RGD:620360_None_cellular response to hypoxia::GO:0071456	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Egfr::RGD:2543_None_positive regulation of fibroblast proliferation::GO:0048146	20
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	positive regulation of fibroblast proliferation::GO:0048146_involved in_AQP1::NCBIGene:358	24
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_positive regulation of epithelial cell migration::GO:0010634	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	positive regulation of epithelial cell migration::GO:0010634_involved in_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	premature death::MP:0002083_has phenotype_Cav1::MGI:102709	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_cellular response to mechanical stimulus::GO:0071260	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	AQP3::NCBIGene:360_involved in_odontogenesis::GO:0042476	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Nfe2l2::MGI:108420_in 1 to 1 orthology relationship with_Nfe2l2::RGD:620360	24
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Nfe2l2::RGD:620360_None_cellular response to hydrogen peroxide::GO:0070301	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp2::RGD:2142_None_cellular response to copper ion::GO:0071280	12
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_pancreatic juice secretion::GO:0030157	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	pancreatic juice secretion::GO:0030157_involved in_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Avp::MGI:88121_in 1 to 1 orthology relationship with_Avp::RGD:2184	12
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Avp::RGD:2184_None_hyperosmotic salinity response::GO:0042538	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	decreased urine osmolality::MP:0002988_has phenotype_Aqp4::MGI:107387	36
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp4::RGD:2143_None_multicellular organismal water homeostasis::GO:0050891	8
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	NFE2L2::NCBIGene:4780_involved in_positive regulation of angiogenesis::GO:0045766	8
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	premature death::MP:0002083_has phenotype_Nfe2l2::MGI:108420	24
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_positive regulation of fibroblast proliferation::GO:0048146	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp4::RGD:2143_None_basal plasma membrane::GO:0009925	8
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	basal plasma membrane::GO:0009925_is part of_AQP1::NCBIGene:358	28
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	aqp1a.1::ZFIN:ZDB-GENE-030131-7764_involved in_carbon dioxide transport::GO:0015670	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_cellular response to UV::GO:0034644	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	AQP3::NCBIGene:360_involved in_glycerol transport::GO:0015793	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp4::RGD:2143_None_sarcolemma::GO:0042383	8
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	sarcolemma::GO:0042383_is part of_AQP1::NCBIGene:358	12
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_glycerol transport::GO:0015793	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Increased blood urea nitrogen::HP:0003138_has phenotype_App::MGI:88059	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	App::MGI:88059_in 1 to 1 orthology relationship with_App::RGD:2139	12
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	App::RGD:2139_None_cellular response to cAMP::GO:0071320	12
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	cellular response to cAMP::GO:0071320_involved in_AQP1::NCBIGene:358	24
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp2::RGD:2142_None_glycerol transport::GO:0015793	12
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	homeostasis/metabolism phenotype::MP:0005376_has phenotype_App::MGI:88059	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Aqp8::MGI:1195271	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp8::MGI:1195271_in 1 to 1 orthology relationship with_AQP8::NCBIGene:343	12
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	AQP8::NCBIGene:343_involved in_cellular response to cAMP::GO:0071320	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_carbon dioxide transmembrane transport::GO:0035378	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	carbon dioxide transmembrane transport::GO:0035378_involved in_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Cav1::RGD:2280_None_basal plasma membrane::GO:0009925	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_response to estrogen::GO:0043627	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	AQP8::NCBIGene:343_involved in_Bile secretion::KEGG-path:maphsa04976	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Bile secretion::KEGG-path:maphsa04976_involved in_AQP1::NCBIGene:358	12
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Egfr::MGI:95294	24
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_axon terminus::GO:0043679	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	axon terminus::GO:0043679_is part of_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Avp::RGD:2184_None_multicellular organismal water homeostasis::GO:0050891	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	premature death::MP:0002083_has phenotype_Spry2::MGI:1345138	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Spry2::MGI:1345138_in 1 to 1 orthology relationship with_SPRY2::NCBIGene:10253	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	SPRY2::NCBIGene:10253_involved in_negative regulation of apoptotic process::GO:0043066	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp8::MGI:1195271_in 1 to 1 orthology relationship with_Aqp8::RGD:2146	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp8::RGD:2146_None_cellular response to cAMP::GO:0071320	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_transepithelial water transport::GO:0035377	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	transepithelial water transport::GO:0035377_involved in_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	aqp1a.1::ZFIN:ZDB-GENE-030131-7764_enables_carbon dioxide transmembrane transporter activity::GO:0035379	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_cellular response to salt stress::GO:0071472	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	cellular response to salt stress::GO:0071472_involved in_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Nfe2l2::RGD:620360_None_positive regulation of angiogenesis::GO:0045766	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_brush border::GO:0005903	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	brush border::GO:0005903_is part of_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	aqp1a.1::ZFIN:ZDB-GENE-030131-7764_enables_ammonium transmembrane transporter activity::GO:0008519	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	ammonium transmembrane transporter activity::GO:0008519_enables_AQP1::NCBIGene:358	8
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_nitric oxide transport::GO:0030185	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	nitric oxide transport::GO:0030185_involved in_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp4::MGI:107387_in 1 to 1 orthology relationship with_AQP4::NCBIGene:361	24
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	AQP4::NCBIGene:361_involved in_renal water homeostasis::GO:0003091	8
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_sarcolemma::GO:0042383	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Nfe2l2::MGI:108420_involved in_cellular response to hydrogen peroxide::GO:0070301	8
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	AVP::NCBIGene:551_involved in_negative regulation of cysteine-type endopeptidase activity involved in apoptotic process::GO:0043154	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_positive regulation of lamellipodium assembly::GO:0010592	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	positive regulation of lamellipodium assembly::GO:0010592_involved in_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Cav1::MGI:102709_in 1 to 1 orthology relationship with_CAV1::NCBIGene:857	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	CAV1::NCBIGene:857_involved in_response to estrogen::GO:0043627	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	AQP8::NCBIGene:343_is part of_apical part of cell::GO:0045177	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	apical part of cell::GO:0045177_is part of_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	premature death::MP:0002083_has phenotype_Fos::MGI:95574	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Fos::MGI:95574_in 1 to 1 orthology relationship with_FOS::NCBIGene:2353	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	FOS::NCBIGene:2353_involved in_response to drug::GO:0042493	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	response to drug::GO:0042493_involved in_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_renal water absorption::GO:0070295	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	decreased circulating glycerol level::MP:0003442_has phenotype_Aqp7::MGI:1314647	16
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp7::MGI:1314647_in 1 to 1 orthology relationship with_AQP7::NCBIGene:364	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	AQP7::NCBIGene:364_involved in_glycerol transport::GO:0015793	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp4::RGD:2143_None_renal water absorption::GO:0070295	8
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_lipid digestion::GO:0044241	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	lipid digestion::GO:0044241_involved in_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	AQP4::NCBIGene:361_involved in_multicellular organismal water homeostasis::GO:0050891	8
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_cellular response to copper ion::GO:0071280	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp7::MGI:1314647_in 1 to 1 orthology relationship with_Aqp7::RGD:2145	12
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp7::RGD:2145_None_glycerol transport::GO:0015793	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_cell volume homeostasis::GO:0006884	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_cellular response to cAMP::GO:0071320	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_corticotropin secretion::GO:0051458	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	corticotropin secretion::GO:0051458_involved in_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_cellular hyperosmotic response::GO:0071474	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	cellular hyperosmotic response::GO:0071474_involved in_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_nitric oxide transmembrane transporter activity::GO:0030184	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	nitric oxide transmembrane transporter activity::GO:0030184_enables_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	AQP4::NCBIGene:361_involved in_Bile secretion::KEGG-path:maphsa04976	8
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_metanephric proximal convoluted tubule segment 2 development::GO:0072232	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	metanephric proximal convoluted tubule segment 2 development::GO:0072232_involved in_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_ammonium transmembrane transporter activity::GO:0008519	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_metanephric glomerulus vasculature development::GO:0072239	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	metanephric glomerulus vasculature development::GO:0072239_involved in_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp7::RGD:2145_None_brush border membrane::GO:0031526	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_cellular response to mercury ion::GO:0071288	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_lateral ventricle development::GO:0021670	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	lateral ventricle development::GO:0021670_involved in_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_cellular response to dexamethasone stimulus::GO:0071549	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	premature death::MP:0002083_has phenotype_App::MGI:88059	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_positive regulation of saliva secretion::GO:0046878	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	positive regulation of saliva secretion::GO:0046878_involved in_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_cellular response to hypoxia::GO:0071456	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_cellular response to retinoic acid::GO:0071300	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	cellular response to retinoic acid::GO:0071300_involved in_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	AVP::NCBIGene:551_involved in_hyperosmotic salinity response::GO:0042538	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	aqp1a.1::ZFIN:ZDB-GENE-030131-7764_None_carbon dioxide transport::GO:0015670	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_basal plasma membrane::GO:0009925	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_symbiont-containing vacuole::GO:0020003	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	symbiont-containing vacuole::GO:0020003_is part of_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_maintenance of symbiont-containing vacuole by host::GO:0085018	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	maintenance of symbiont-containing vacuole by host::GO:0085018_involved in_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	AVP::NCBIGene:551_involved in_negative regulation of apoptotic process::GO:0043066	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Avp::RGD:2184_None_negative regulation of cysteine-type endopeptidase activity involved in apoptotic process::GO:0043154	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_odontogenesis::GO:0042476	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp7::RGD:2145_None_renal water absorption::GO:0070295	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_sensory perception of pain::GO:0019233	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	sensory perception of pain::GO:0019233_involved in_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_glomerular filtration::GO:0003094	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	glomerular filtration::GO:0003094_involved in_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_symbiont-containing vacuole membrane::GO:0020005	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	symbiont-containing vacuole membrane::GO:0020005_is part of_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp4::RGD:2143_None_hyperosmotic salinity response::GO:0042538	8
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_positive regulation of angiogenesis::GO:0045766	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	Aqp1::RGD:2141_None_establishment or maintenance of actin cytoskeleton polarity::GO:0030950	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	establishment or maintenance of actin cytoskeleton polarity::GO:0030950_involved in_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	aqp1a.1::ZFIN:ZDB-GENE-030131-7764_involved in_ammonium transport::GO:0015696	4
AQP11::NCBIGene:282679	AQP1::NCBIGene:358	1028	ammonium transport::GO:0015696_involved in_AQP1::NCBIGene:358	4
AQP11::NCBIGene:282679	Aqp1::NCBIGene:11826	0	NA	0
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	AQP11::NCBIGene:282679_in 1 to 1 orthology relationship with_Aqp11::MGI:1913583	208
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Aqp11::MGI:1913583_has phenotype_Elevated serum creatinine::HP:0003259	36
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Elevated serum creatinine::HP:0003259_has phenotype_Ikzf3::MGI:1342542	4
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Ikzf3::MGI:1342542_in 1 to 1 orthology relationship with_IKZF3::NCBIGene:22806	12
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	IKZF3::NCBIGene:22806_involved in_transcription from RNA polymerase II promoter::GO:0006366	12
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	transcription from RNA polymerase II promoter::GO:0006366_involved in_NFE2L1::NCBIGene:4779	24
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Aqp11::MGI:1913583_has phenotype_premature death::MP:0002083	56
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	premature death::MP:0002083_has phenotype_Nfe2l2::MGI:108420	36
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Nfe2l2::MGI:108420_in 1 to 1 orthology relationship with_NFE2L2::NCBIGene:4780	48
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	NFE2L2::NCBIGene:4780_involved in_transcription from RNA polymerase II promoter::GO:0006366	8
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	premature death::MP:0002083_has phenotype_Fos::MGI:95574	8
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Fos::MGI:95574_in 1 to 1 orthology relationship with_FOS::NCBIGene:2353	8
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	FOS::NCBIGene:2353_involved in_inflammatory response::GO:0006954	4
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	inflammatory response::GO:0006954_involved in_NFE2L1::NCBIGene:4779	20
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Nfe2l2::MGI:108420_in 1 to 1 orthology relationship with_Nfe2l2::RGD:620360	8
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Nfe2l2::RGD:620360_None_RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980	16
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980_enables_NFE2L1::NCBIGene:4779	48
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Elevated serum creatinine::HP:0003259_has phenotype_NFE2L2::NCBIGene:4780	28
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	NFE2L2::NCBIGene:4780_in 1 to 1 orthology relationship with_Nfe2l2::RGD:620360	8
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	NFE2L2::NCBIGene:4780_in 1 to 1 orthology relationship with_Nfe2l2::MGI:108420	48
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Nfe2l2::MGI:108420_involved in_cellular response to oxidative stress::GO:0034599	8
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	cellular response to oxidative stress::GO:0034599_involved in_NFE2L1::NCBIGene:4779	24
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Aqp11::MGI:1913583_has phenotype_Leukopenia::HP:0001882	36
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Leukopenia::HP:0001882_has phenotype_NFE2L2::NCBIGene:4780	28
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Nfe2l2::MGI:108420_involved in_inflammatory response::GO:0006954	8
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Nfe2l2::MGI:108420_None_RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980	8
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Aqp11::MGI:1913583_has phenotype_homeostasis/metabolism phenotype::MP:0005376	52
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Nfe2l2::MGI:108420	36
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	NFE2L2::NCBIGene:4780_enables_RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980	8
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Aqp11::MGI:1913583_has phenotype_Increased blood urea nitrogen::HP:0003138	8
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Increased blood urea nitrogen::HP:0003138_has phenotype_Egfr::MGI:95294	4
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Egfr::MGI:95294_in 1 to 1 orthology relationship with_EGFR::NCBIGene:1956	20
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	EGFR::NCBIGene:1956_is part of_endoplasmic reticulum membrane::GO:0005789	20
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	endoplasmic reticulum membrane::GO:0005789_is part of_NFE2L1::NCBIGene:4779	40
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Nfe2l1::MGI:99421	8
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Nfe2l1::MGI:99421_in 1 to 1 orthology relationship with_Nfe2l1::RGD:1311972	16
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Nfe2l1::RGD:1311972_None_erythrocyte differentiation::GO:0030218	8
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	erythrocyte differentiation::GO:0030218_involved in_NFE2L1::NCBIGene:4779	8
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	NFE2L2::NCBIGene:4780_enables_transcription regulatory region sequence-specific DNA binding::GO:0000976	8
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	transcription regulatory region sequence-specific DNA binding::GO:0000976_enables_NFE2L1::NCBIGene:4779	24
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Aqp11::MGI:1913583_has phenotype_abnormal hepatocyte morphology::MP:0000607	8
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	abnormal hepatocyte morphology::MP:0000607_has phenotype_Egfr::MGI:95294	4
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	NFE2L2::NCBIGene:4780_involved in_inflammatory response::GO:0006954	8
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Cav1::MGI:102709	4
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Cav1::MGI:102709_in 1 to 1 orthology relationship with_CAV1::NCBIGene:857	16
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	CAV1::NCBIGene:857_is part of_endoplasmic reticulum membrane::GO:0005789	16
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	premature death::MP:0002083_has phenotype_Ikzf3::MGI:1342542	4
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Nfe2l2::MGI:108420_enables_RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980	8
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Nfe2l1::RGD:1311972_None_RNA polymerase II distal enhancer sequence-specific DNA binding::GO:0000980	8
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Elevated serum creatinine::HP:0003259_has phenotype_Egfr::MGI:95294	4
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Leukopenia::HP:0001882_has phenotype_Ikzf3::MGI:1342542	4
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	NFE2L2::NCBIGene:4780_enables_protein domain specific binding::GO:0019904	8
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	protein domain specific binding::GO:0019904_enables_NFE2L1::NCBIGene:4779	16
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Nfe2l2::MGI:108420_in 1 to 1 orthology relationship with_nfe2l2a::ZFIN:ZDB-GENE-030723-2	16
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	nfe2l2a::ZFIN:ZDB-GENE-030723-2_enables_transcription regulatory region sequence-specific DNA binding::GO:0000976	8
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Nfe2l2::MGI:108420_enables_protein domain specific binding::GO:0019904	8
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	nfe2l2a::ZFIN:ZDB-GENE-030723-2_involved in_cellular response to oxidative stress::GO:0034599	8
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	premature death::MP:0002083_has phenotype_Cav1::MGI:102709	4
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Aqp11::MGI:1913583_has phenotype_increased circulating aspartate transaminase level::MP:0005343	8
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	increased circulating aspartate transaminase level::MP:0005343_has phenotype_Nfe2l1::MGI:99421	8
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Leukopenia::HP:0001882_has phenotype_Egfr::MGI:95294	4
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Nfe2l2::MGI:108420_enables_transcription regulatory region sequence-specific DNA binding::GO:0000976	8
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	FOS::NCBIGene:2353_involved in_transcription from RNA polymerase II promoter::GO:0006366	4
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	premature death::MP:0002083_has phenotype_Siah1a::MGI:108064	4
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Siah1a::MGI:108064_in 1 to 1 orthology relationship with_SIAH1::NCBIGene:6477	4
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	SIAH1::NCBIGene:6477_involved in_anatomical structure morphogenesis::GO:0009653	4
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	anatomical structure morphogenesis::GO:0009653_involved in_NFE2L1::NCBIGene:4779	4
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Increased blood urea nitrogen::HP:0003138_has phenotype_Cav1::MGI:102709	4
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Aqp11::MGI:1913583_has phenotype_decreased circulating glycerol level::MP:0003442	4
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	decreased circulating glycerol level::MP:0003442_has phenotype_Cav1::MGI:102709	4
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	NFE2L2::NCBIGene:4780_involved in_cellular response to oxidative stress::GO:0034599	8
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	abnormal hepatocyte morphology::MP:0000607_has phenotype_Amfr::MGI:1345634	4
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	Amfr::MGI:1345634_in 1 to 1 orthology relationship with_AMFR::NCBIGene:267	4
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	AMFR::NCBIGene:267_is part of_endoplasmic reticulum membrane::GO:0005789	4
AQP11::NCBIGene:282679	NFE2L1::NCBIGene:4779	208	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Egfr::MGI:95294	4
AQP11::NCBIGene:282679	ENGASE::NCBIGene:64772	16	AQP11::NCBIGene:282679_in 1 to 1 orthology relationship with_Aqp11::MGI:1913583	16
AQP11::NCBIGene:282679	ENGASE::NCBIGene:64772	16	Aqp11::MGI:1913583_has phenotype_abnormal hepatocyte morphology::MP:0000607	4
AQP11::NCBIGene:282679	ENGASE::NCBIGene:64772	16	abnormal hepatocyte morphology::MP:0000607_has phenotype_Amfr::MGI:1345634	4
AQP11::NCBIGene:282679	ENGASE::NCBIGene:64772	16	Amfr::MGI:1345634_in 1 to 1 orthology relationship with_AMFR::NCBIGene:267	4
AQP11::NCBIGene:282679	ENGASE::NCBIGene:64772	16	AMFR::NCBIGene:267_involved in_protein folding::GO:0006457	4
AQP11::NCBIGene:282679	ENGASE::NCBIGene:64772	16	protein folding::GO:0006457_involved in_ENGASE::NCBIGene:64772	12
AQP11::NCBIGene:282679	ENGASE::NCBIGene:64772	16	Aqp11::MGI:1913583_has phenotype_premature death::MP:0002083	12
AQP11::NCBIGene:282679	ENGASE::NCBIGene:64772	16	premature death::MP:0002083_has phenotype_Rad23b::MGI:105128	4
AQP11::NCBIGene:282679	ENGASE::NCBIGene:64772	16	Rad23b::MGI:105128_in 1 to 1 orthology relationship with_RAD23B::NCBIGene:5887	4
AQP11::NCBIGene:282679	ENGASE::NCBIGene:64772	16	RAD23B::NCBIGene:5887_involved in_protein folding::GO:0006457	4
AQP11::NCBIGene:282679	ENGASE::NCBIGene:64772	16	premature death::MP:0002083_has phenotype_Psmc1::MGI:106054	4
AQP11::NCBIGene:282679	ENGASE::NCBIGene:64772	16	Psmc1::MGI:106054_in 1 to 1 orthology relationship with_PSMC1::NCBIGene:5700	4
AQP11::NCBIGene:282679	ENGASE::NCBIGene:64772	16	PSMC1::NCBIGene:5700_involved in_protein folding::GO:0006457	4
AQP11::NCBIGene:282679	ENGASE::NCBIGene:64772	16	premature death::MP:0002083_has phenotype_Capn1::MGI:88263	4
AQP11::NCBIGene:282679	ENGASE::NCBIGene:64772	16	Capn1::MGI:88263_in 1 to 1 orthology relationship with_CAPN1::NCBIGene:823	4
AQP11::NCBIGene:282679	ENGASE::NCBIGene:64772	16	CAPN1::NCBIGene:823_is part of_lysosome::GO:0005764	4
AQP11::NCBIGene:282679	ENGASE::NCBIGene:64772	16	lysosome::GO:0005764_is part of_ENGASE::NCBIGene:64772	4
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	AQP11::NCBIGene:282679_in 1 to 1 orthology relationship with_Aqp11::MGI:1913583	372
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp11::MGI:1913583_has phenotype_Increased blood urea nitrogen::HP:0003138	68
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Increased blood urea nitrogen::HP:0003138_has phenotype_Egfr::MGI:95294	8
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Egfr::MGI:95294_in 1 to 1 orthology relationship with_EGFR::NCBIGene:1956	20
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	EGFR::NCBIGene:1956_involved in_response to calcium ion::GO:0051592	20
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	response to calcium ion::GO:0051592_involved in_AQP3::NCBIGene:360	84
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp11::MGI:1913583_has phenotype_decreased urine osmolality::MP:0002988	100
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	decreased urine osmolality::MP:0002988_has phenotype_Aqp1::MGI:103201	36
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp1::MGI:103201_in 1 to 1 orthology relationship with_Aqp1::RGD:2141	16
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp1::RGD:2141_None_odontogenesis::GO:0042476	4
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	odontogenesis::GO:0042476_involved in_AQP3::NCBIGene:360	24
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp11::MGI:1913583_has phenotype_decreased circulating glycerol level::MP:0003442	40
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	decreased circulating glycerol level::MP:0003442_has phenotype_Aqp7::MGI:1314647	32
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp7::MGI:1314647_in 1 to 1 orthology relationship with_Aqp7::RGD:2145	16
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp7::RGD:2145_None_glycerol transport::GO:0015793	4
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	glycerol transport::GO:0015793_involved in_AQP3::NCBIGene:360	56
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Increased blood urea nitrogen::HP:0003138_has phenotype_Cav1::MGI:102709	8
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Cav1::MGI:102709_in 1 to 1 orthology relationship with_CAV1::NCBIGene:857	16
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	CAV1::NCBIGene:857_involved in_response to calcium ion::GO:0051592	16
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp1::MGI:103201_in 1 to 1 orthology relationship with_AQP1::NCBIGene:358	20
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	AQP1::NCBIGene:358_involved in_odontogenesis::GO:0042476	4
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	decreased urine osmolality::MP:0002988_has phenotype_Aqp3::MGI:1333777	32
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp3::MGI:1333777_in 1 to 1 orthology relationship with_Aqp3::RGD:68428	128
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp3::RGD:68428_None_response to retinoic acid::GO:0032526	16
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	response to retinoic acid::GO:0032526_involved in_AQP3::NCBIGene:360	16
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp3::RGD:68428_None_renal water absorption::GO:0070295	16
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	renal water absorption::GO:0070295_involved in_AQP3::NCBIGene:360	36
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp11::MGI:1913583_has phenotype_Hypotriglyceridemia::HP:0012153	32
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Hypotriglyceridemia::HP:0012153_has phenotype_Aqp3::MGI:1333777	32
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp3::RGD:68428_None_glycerol transport::GO:0015793	16
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Increased blood urea nitrogen::HP:0003138_has phenotype_Aqp2::MGI:1096865	20
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp2::MGI:1096865_in 1 to 1 orthology relationship with_AQP2::NCBIGene:359	36
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	AQP2::NCBIGene:359_involved in_glycerol transport::GO:0015793	12
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp3::RGD:68428_None_cellular response to hypoxia::GO:0071456	16
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	cellular response to hypoxia::GO:0071456_involved in_AQP3::NCBIGene:360	48
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	decreased circulating glycerol level::MP:0003442_has phenotype_Cav1::MGI:102709	8
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp11::MGI:1913583_has phenotype_premature death::MP:0002083	36
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	premature death::MP:0002083_has phenotype_Aqp2::MGI:1096865	20
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp3::RGD:68428_None_urea transport::GO:0015840	16
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	urea transport::GO:0015840_involved in_AQP3::NCBIGene:360	20
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	AQP2::NCBIGene:359_involved in_renal water homeostasis::GO:0003091	12
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	renal water homeostasis::GO:0003091_involved in_AQP3::NCBIGene:360	28
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp3::RGD:68428_None_cellular response to oxygen-glucose deprivation::GO:0090650	16
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	cellular response to oxygen-glucose deprivation::GO:0090650_involved in_AQP3::NCBIGene:360	16
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Cav1::MGI:102709_in 1 to 1 orthology relationship with_Cav1::RGD:2280	16
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Cav1::RGD:2280_None_response to calcium ion::GO:0051592	16
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp11::MGI:1913583_has phenotype_Elevated serum creatinine::HP:0003259	44
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Elevated serum creatinine::HP:0003259_has phenotype_NFE2L2::NCBIGene:4780	4
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	NFE2L2::NCBIGene:4780_in 1 to 1 orthology relationship with_Nfe2l2::RGD:620360	8
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Nfe2l2::RGD:620360_None_cellular response to hypoxia::GO:0071456	16
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp3::RGD:68428_None_odontogenesis::GO:0042476	16
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp11::MGI:1913583_has phenotype_Leukopenia::HP:0001882	12
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Leukopenia::HP:0001882_has phenotype_Egfr::MGI:95294	8
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Egfr::MGI:95294_in 1 to 1 orthology relationship with_Egfr::RGD:2543	20
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Egfr::RGD:2543_None_response to calcium ion::GO:0051592	20
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp11::MGI:1913583_has phenotype_homeostasis/metabolism phenotype::MP:0005376	32
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Nfe2l2::MGI:108420	8
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Nfe2l2::MGI:108420_in 1 to 1 orthology relationship with_Nfe2l2::RGD:620360	8
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp7::MGI:1314647_in 1 to 1 orthology relationship with_AQP7::NCBIGene:364	16
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	AQP7::NCBIGene:364_is part of_cell-cell junction::GO:0005911	4
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	cell-cell junction::GO:0005911_is part of_AQP3::NCBIGene:360	4
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Elevated serum creatinine::HP:0003259_has phenotype_Aqp3::MGI:1333777	32
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp3::RGD:68428_None_glycerol channel activity::GO:0015254	16
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	glycerol channel activity::GO:0015254_enables_AQP3::NCBIGene:360	24
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Increased blood urea nitrogen::HP:0003138_has phenotype_Aqp3::MGI:1333777	32
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Cav1::MGI:102709	8
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	decreased urine osmolality::MP:0002988_has phenotype_Aqp4::MGI:107387	8
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp4::MGI:107387_in 1 to 1 orthology relationship with_Aqp4::RGD:2143	8
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp4::RGD:2143_None_renal water absorption::GO:0070295	8
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp2::MGI:1096865_in 1 to 1 orthology relationship with_Aqp2::RGD:2142	24
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp2::RGD:2142_None_glycerol transport::GO:0015793	12
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	decreased urine osmolality::MP:0002988_has phenotype_Aqp2::MGI:1096865	20
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp2::RGD:2142_None_response to calcium ion::GO:0051592	12
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	AQP2::NCBIGene:359_involved in_excretion::GO:0007588	12
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	excretion::GO:0007588_involved in_AQP3::NCBIGene:360	16
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	decreased urine osmolality::MP:0002988_has phenotype_Avp::MGI:88121	4
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Avp::MGI:88121_in 1 to 1 orthology relationship with_AVP::NCBIGene:551	4
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	AVP::NCBIGene:551_involved in_renal water homeostasis::GO:0003091	4
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp7::RGD:2145_None_glycerol channel activity::GO:0015254	4
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	premature death::MP:0002083_has phenotype_Cav1::MGI:102709	8
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Leukopenia::HP:0001882_has phenotype_NFE2L2::NCBIGene:4780	4
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp11::MGI:1913583_has phenotype_abnormal hepatocyte morphology::MP:0000607	8
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	abnormal hepatocyte morphology::MP:0000607_has phenotype_Egfr::MGI:95294	8
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	AQP7::NCBIGene:364_involved in_glycerol transport::GO:0015793	4
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Aqp4::MGI:107387	8
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	AQP1::NCBIGene:358_involved in_cellular response to hypoxia::GO:0071456	4
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp1::RGD:2141_None_cellular response to hypoxia::GO:0071456	4
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp1::RGD:2141_None_renal water absorption::GO:0070295	4
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	homeostasis/metabolism phenotype::MP:0005376_has phenotype_Egfr::MGI:95294	8
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp7::RGD:2145_None_urea transport::GO:0015840	4
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp7::RGD:2145_None_renal water absorption::GO:0070295	4
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	premature death::MP:0002083_has phenotype_Nfe2l2::MGI:108420	8
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Nfe2l2::MGI:108420_in 1 to 1 orthology relationship with_NFE2L2::NCBIGene:4780	8
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	NFE2L2::NCBIGene:4780_involved in_cellular response to hypoxia::GO:0071456	8
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	AQP1::NCBIGene:358_involved in_glycerol transport::GO:0015793	4
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp1::RGD:2141_None_glycerol transport::GO:0015793	4
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	AQP7::NCBIGene:364_involved in_excretion::GO:0007588	4
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Elevated serum creatinine::HP:0003259_has phenotype_Egfr::MGI:95294	8
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	Aqp4::MGI:107387_in 1 to 1 orthology relationship with_AQP4::NCBIGene:361	8
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	AQP4::NCBIGene:361_involved in_renal water homeostasis::GO:0003091	8
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	AQP1::NCBIGene:358_involved in_renal water absorption::GO:0070295	4
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	AQP1::NCBIGene:358_involved in_renal water homeostasis::GO:0003091	4
AQP11::NCBIGene:282679	AQP3::NCBIGene:360	372	AQP7::NCBIGene:364_enables_glycerol channel activity::GO:0015254	4
